Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
40763082	pf-ld	U/l (u/l)	3233	4268	0.19%
40763082	pf-ld	— (—)	308	336	100.00%	Distribution not available
40763082	pf-ld	U/l_37C (u/l)	164	197	0.00%
40763082	pf-ld	U/L (u/l)	133	161	0.00%
40763082	pf-ld	U/l_______ (u/l)	74	90	0.00%
40763082	pf-ld	U/l37C (u/l)	62	69	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Abnormal findings on diagnostic imaging of lung

931

2231

4.06

319.29

1.4

1.3

554.12

445.63

u/l

0.62

886

2108

Asthma

505

239

10.99

318.08

1.4

1.1

596.75

203.78

u/l

2.14

475

217

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1068

2562

3.70

315.41

1.4

1.3

533.23

439.92

u/l

0.60

1016

2420

Pneumonia, organism unspecified

1472

1621

6.36

307.65

1.3

572.08

389.86

u/l

2.04

1400

1540

All-cause Heart Failure

1181

1652

5.13

307.65

1.4

1.3

321.99

619.89

u/l

3.42

1122

1559

ILD differential diagnosis

717

241

15.09

307.65

1.4

1.1

391.24

204.57

u/l

7.70

685

219

Other medical care

1077

1610

5.80

307.65

1.4

1.3

397.67

543.17

u/l

1.54

1035

1515

Asthma, unspecified (mode), excluding more controls

420

32.35

307.65

1.4

1.1

608.83

266.69

u/l

1.28

392

Bacterial infection, other or unspecified

985

1877

4.54

307.65

1.4

1.3

502.50

417.33

u/l

0.64

929

1797

Influenza and pneumonia

1479

1630

5.70

307.65

1.3

609.38

390.60

u/l

2.54

1407

1548

Suppurative and necrotic conditions of lower respiratory tract

464

226

25.41

307.65

1.4

1.3

1663.67

297.81

u/l

7.76

422

219

Pyothorax

425

186

29.82

307.65

1.4

1.3

1762.09

288.95

u/l

7.64

387

180

All pneumoniae

1524

1675

6.02

307.65

1.3

604.07

387.27

u/l

2.61

1446

1585

Other pleural conditions

1077

206

67.92

307.65

1.5

1.2

393.54

361.30

u/l

0.19

1039

192

Later onset COPD, excluding more controls

361

163

17.45

307.65

1.4

1.1

551.94

168.95

u/l

3.25

338

146

Non-small cell lung cancer, including Hilmo

490

562

8.68

307.65

1.3

614.54

296.08

u/l

3.64

476

519

Pleural effusion

1997

333

82.45

307.65

1.5

1.1

384.68

440.25

u/l

0.26

1930

305

Asthma (only as main-diagnosis), excluding more controls

415

24.35

307.65

1.4

1.1

431.51

275.30

u/l

1.45

386

COPD differential diagnosis

717

241

15.09

307.65

1.4

1.1

391.24

204.57

u/l

7.70

685

219

Excluding asthma or asthma-COPD overlap

718

240

15.18

307.65

1.4

1.1

390.31

203.45

u/l

7.68

685

218

Other bacterial diseases

1263

2161

3.93

307.65

1.3

607.69

421.42

u/l

1.49

1187

2065

Any death

1172

1506

5.60

307.65

1.3

536.81

445.20

u/l

0.55

1124

1423

1333

1389

5.71

307.65

1.3

601.21

370.61

u/l

2.58

1271

1319

COPD (mode)

494

192

20.64

307.65

1.3

1.1

640.04

163.86

u/l

2.74

468

174

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1530

1702

6.10

307.65

1.3

604.03

385.79

u/l

2.66

1453

1610

Heart failure,strict

1092

1229

6.41

307.65

1.4

1.3

329.98

682.44

u/l

3.76

1038

1163

Heart failure, not strict

1215

1474

5.67

307.65

1.4

1.3

378.94

678.13

u/l

3.28

1156

1397

Malignant neoplasm of respiratory system and intrathoracic organs

728

706

9.10

307.65

1.4

1.3

654.07

346.95

u/l

2.32

707

659

Lung cancer and mesothelioma

765

139

50.49

307.65

1.3

1.1

631.05

176.60

u/l

5.19

744

129

Dyspnoea

1253

2465

3.73

307.65

1.4

1.3

449.42

487.83

u/l

0.27

1199

2320

Other diseases of pleura

2592

879

28.61

307.65

1.4

1.1

393.22

677.44

u/l

1.78

2490

802

Other bacterial diseases, including avohilmo

1214

2026

3.79

307.65

1.3

623.93

421.54

u/l

1.60

1143

1934

Other pulmonary diagnosis

732

240

15.48

307.65

1.4

1.1

381.47

203.45

u/l

7.20

699

218

Pneumonias (Asthma/COPD co-morbidities)

1530

1678

6.07

307.65

1.3

603.29

387.02

u/l

2.61

1453

1587

Asthma, excluding more controls

471

25.68

307.65

1.4

1.1

618.98

275.30

u/l

1.47

443

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

805

762

9.24

307.65

1.3

629.25

339.75

u/l

2.46

780

714

Asthma, unspecified (mode)

440

235

13.67

307.65

1.4

1.1

589.89

201.38

u/l

1.75

410

213

Bacterial infection, other or unspecified, including avohilmo

1042

1911

4.57

307.65

1.4

1.3

542.89

405.98

u/l

1.21

982

1829

Malignant neoplasm of bronchus and lung, including Hilmo

640

713

7.90

307.65

1.3

677.10

315.94

u/l

2.61

620

666

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1333

1389

5.71

307.65

1.3

601.21

370.61

u/l

2.58

1271

1319

Heart failure, strict

1212

1678

5.18

307.65

1.4

1.3

316.43

615.87

u/l

3.58

1152

1583

Malignant neoplasm of bronchus and lung

560

641

7.70

307.65

1.3

722.07

293.72

u/l

2.85

545

596

Diseases of the respiratory system

520

260

10.13

307.43

1.4

1.1

365.46

237.92

u/l

3.20

497

237

Heart failure and antihypertensive medication

488

389

8.42

298.07

1.4

1.2

329.25

746.04

u/l

2.08

463

368

Non-small cell lung cancer

361

402

9.47

293.26

1.3

652.01

274.04

u/l

3.73

351

374

Asthma (only as main-diagnosis)

446

239

10.52

289.43

1.4

1.1

424.72

203.78

u/l

4.02

413

217

Renal tubulo-interstitial diseases

1110

2375

3.47

284.99

1.3

429.15

509.92

u/l

0.52

1039

2268

Non-ischemic cardiomyopathy

630

976

5.29

279.61

1.4

1.3

418.78

605.15

u/l

0.74

600

928

Asthma (mode)

453

241

9.95

273.71

1.4

1.1

511.22

204.57

u/l

3.85

427

219

Early onset COPD, excluding more controls

218

126

17.63

267.01

1.3

1.1

708.27

189.50

u/l

1.11

209

119

Persons encountering health services for specific procedures and health care

1134

1971

3.43

266.77

1.3

452.46

564.11

u/l

0.88

1082

1849

Bacterial Sepsis

845

1833

3.90

264.15

1.4

1.3

368.38

504.69

u/l

1.11

783

1750

Renal failure

913

2172

3.67

263.83

1.4

1.3

246.39

544.52

u/l

7.54

848

2071

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1175

2496

3.21

261.01

1.4

1.3

400.20

521.29

u/l

1.22

1106

2369

All chronic kidney diseases

875

1901

3.74

256.12

1.4

1.3

290.61

521.39

u/l

5.17

819

1816

Non-small cell lung cancer, adenocarcinoma

251

207

13.27

255.82

1.3

797.29

258.70

u/l

3.78

244

195

Bacterial pneumoniae

612

1151

4.77

252.90

1.4

1.3

639.69

365.67

u/l

1.85

576

1101

Oxycodone

713

1494

4.18

247.19

1.3

429.96

516.47

u/l

0.62

688

1411

Bacterial pneumonia, not elsewhere classified

588

1112

4.74

241.52

1.4

1.3

631.80

369.30

u/l

1.65

556

1063

Septicaemia

721

1680

4.00

240.86

1.4

1.3

560.29

404.97

u/l

0.83

664

1608

Implicit bacterial Sepsis

760

1741

3.83

234.45

1.4

1.3

343.13

507.62

u/l

1.33

706

1665

Implicit bacterial Sepsis, including avohilmo

797

1821

3.72

234.02

1.4

1.3

344.50

503.71

u/l

1.34

739

1740

Heart failure and bmi 25plus

596

816

5.01

233.40

1.3

427.74

695.26

u/l

1.03

565

768

Explicit Sepsis, including avohilmo

742

1799

3.82

232.06

1.4

1.3

551.50

502.50

u/l

0.18

685

1718

Explicit Sepsis

730

1786

3.80

227.24

1.4

1.3

555.81

501.19

u/l

0.20

673

1706

All kidney diseases

1063

2316

3.11

223.96

1.3

418.79

525.61

u/l

0.77

996

2212

Other septicaemia, including avohilmo

656

1614

3.90

213.48

1.4

1.3

547.42

408.11

u/l

0.64

609

1546

Implicit Sepsis

938

2209

3.17

209.63

1.4

1.3

375.76

500.35

u/l

1.10

881

2109

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

369

622

6.15

209.23

1.2

1.3

448.88

367.33

u/l

1.00

350

587

Other septicaemia

643

1593

3.89

208.88

1.4

1.3

552.48

406.79

u/l

0.66

596

1526

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

429

807

5.31

206.45

1.3

500.89

353.87

u/l

1.33

408

755

Liquid cancers, including Hilmo

523

1034

4.56

204.96

1.3

347.25

394.99

u/l

0.38

493

961

Heart failure and coronary heart disease

805

1651

3.50

204.45

1.4

1.3

210.34

583.23

u/l

8.11

762

1576

Other heart diseases, wide

775

1296

3.65

201.51

1.4

1.3

313.66

717.42

u/l

9.24

737

1224

COPD/asthma related infections

927

1389

3.37

200.42

1.4

1.3

424.28

370.61

u/l

0.74

879

1319

COPD/asthma/ILD related infections

927

1389

3.37

200.42

1.4

1.3

424.28

370.61

u/l

0.74

879

1319

Pneumothorax

170

108

16.61

199.82

1.5

1.2

520.54

472.99

u/l

0.14

159

102

Abnormalities of breathing

897

1582

3.28

195.06

1.4

1.3

435.29

537.12

u/l

0.78

856

1491

Chronic kidney disease

636

1719

3.66

189.04

1.4

1.3

235.83

517.68

u/l

6.03

593

1639

Valvular heart disease excluding rheumatic fever

575

1002

4.17

188.08

1.4

1.3

268.44

712.21

u/l

8.79

543

946

Non-small cell lung cancer, adenocarcinoma, helper endpoint

251

319

8.57

187.09

1.3

1.4

797.29

321.02

u/l

3.08

244

302

Non-rheumatic valve diseases

572

1000

4.15

186.11

1.4

1.3

268.47

712.88

u/l

8.78

540

944

Malignant neoplasm

781

1341

3.45

184.72

1.3

403.44

429.28

u/l

0.21

749

1249

Implicit Sepsis, including avohilmo

918

2230

2.97

183.19

1.4

1.3

377.83

505.10

u/l

1.11

861

2129

Malignant neoplasm

775

1340

3.42

181.43

1.3

403.14

428.84

u/l

0.21

743

1248

Non-invasive ventilation

311

415

6.59

180.08

1.4

1.3

553.41

621.41

u/l

0.11

283

396

Other heart diseases

375

404

6.10

178.75

1.4

1.2

346.01

795.68

u/l

3.59

356

382

Malignant neoplasm, including Hilmo

773

1342

3.39

178.03

1.3

408.61

430.21

u/l

0.17

737

1250

Anaemias

185

20.69

178.00

1.4

1.3

316.66

922.45

u/l

2.23

173

Malignant neoplasm, wide definition

773

1347

3.37

176.87

1.3

410.37

429.85

u/l

0.15

737

1255

Liquid cancers

433

933

4.49

170.58

1.4

1.3

335.69

400.19

u/l

0.50

409

873

Acute renal failure

454

1091

4.30

170.37

1.4

1.3

242.03

502.50

u/l

3.13

423

1043

Dialysis, with operation codes

291

479

6.36

169.57

1.5

1.3

241.33

394.00

u/l

3.22

275

459

Solid cancers

750

1332

3.33

169.09

1.4

1.3

448.65

429.43

u/l

0.11

720

1240

Fever of other and unknown origin

680

1841

3.24

165.23

1.4

1.3

502.67

524.21

u/l

0.08

634

1751

Solid cancers, including Hilmo

749

1341

3.28

164.91

1.3

414.17

428.99

u/l

0.11

715

1249

Nephropathy related operations

287

482

6.24

163.99

1.4

1.3

228.64

367.44

u/l

3.27

271

457

Any event in cancer register

775

1443

3.16

161.22

1.4

1.3

400.14

419.13

u/l

0.16

741

1343

Condition for Implicit Sepsis (Organ dysfunction codes)

890

2204

2.83

161.11

1.4

1.3

377.41

515.63

u/l

1.21

834

2105

Any gastric operation

574

721

4.02

157.32

1.3

353.65

607.20

u/l

1.69

548

679

GASTRO-related operations

574

721

4.02

157.32

1.3

353.65

607.20

u/l

1.69

548

679

Respiratory insufficiency

124

18.74

155.60

1.5

1.1

284.46

169.57

u/l

1.45

113

Non-allergic asthma (mode), excluding more controls

108

25.73

154.49

1.4

1.0

662.74

178.63

u/l

1.25

100

Erysipelas, including avohilmo

773

1995

2.90

149.57

1.3

579.46

429.24

u/l

0.66

724

1911

Atrial fibrillation and flutter

310

341

5.95

143.82

1.4

1.2

375.80

743.21

u/l

2.50

300

322

Aplastic and other anaemias

714

2303

2.89

143.44

1.4

1.3

367.45

467.49

u/l

0.67

673

2186

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

847

2122

2.72

141.94

1.3

406.82

525.29

u/l

0.84

799

2023

Bacterial pneumonia (organism specified)

650

1985

3.02

140.93

1.4

1.3

622.93

401.67

u/l

1.45

611

1891

First line medication for Crohn's disease

1005

2147

2.54

138.01

1.4

1.3

522.05

498.14

u/l

0.11

958

2023

Diseases of arteries, arterioles and capillaries (FINNGEN)

265

291

6.39

135.19

1.3

1.2

281.19

763.77

u/l

3.91

257

274

Atrial fibrillation and flutter with reimbursement

284

297

6.13

133.68

1.3

1.2

352.60

778.83

u/l

2.65

274

281

Other anaemias

660

2231

2.82

127.49

1.4

1.3

382.69

471.57

u/l

0.52

622

2117

Care involving dialysis

183

250

7.68

127.26

1.5

1.3

193.83

355.58

u/l

2.65

172

234

Other and unspecified anaemias

654

2223

2.81

125.81

1.4

1.3

380.93

472.50

u/l

0.54

616

2109

Pleural plaque

171

228

7.79

121.19

1.4

1.1

391.00

463.75

u/l

0.24

164

204

Erysipelas

624

1961

2.78

115.80

1.3

641.47

421.33

u/l

0.83

581

1878

Secondary uncertain malignant neoplasm

226

432

5.39

112.11

1.3

341.44

304.44

u/l

0.37

216

402

COPD

641

1974

2.68

109.12

1.3

587.57

420.46

u/l

0.77

606

1868

Oral corticosteroids

982

2560

2.27

108.72

1.4

1.3

494.44

482.30

u/l

0.06

931

2425

Cardiomyopathy

244

512

4.87

108.36

1.4

1.3

376.23

805.71

u/l

1.27

231

486

ILD medications: prednisolone, methylprednisolone, prednisone

966

2379

2.27

106.22

1.4

1.3

506.06

485.81

u/l

0.09

916

2250

Ascites

182

305

6.25

104.40

1.3

325.98

347.80

u/l

0.13

171

292

Other chronic obstructive pulmonary disease

616

1935

2.65

102.63

1.3

594.29

423.40

u/l

0.75

583

1831

Cardiac arrhythmias

405

753

3.47

100.71

1.4

1.3

342.47

722.95

u/l

4.65

387

714

Extracorporeal dialysis

156

236

7.00

99.16

1.5

1.3

185.95

368.42

u/l

3.09

145

226

ILD medications

963

2384

2.19

96.50

1.4

1.3

514.12

485.86

u/l

0.13

911

2255

Acute tubulo-interstitial nephritis

630

2130

2.52

96.45

1.3

554.20

509.91

u/l

0.14

589

2038

Covid-19 confirmed case

508

1876

2.75

95.32

1.3

445.07

469.02

u/l

0.11

486

1772

Other chronic obstructive pulmonary disease, including avohilmo

685

2388

2.39

92.24

1.3

603.28

445.33

u/l

0.75

647

2261

Codes for special purposes

585

2343

2.50

91.21

1.4

1.3

438.68

477.13

u/l

0.22

559

2208

Cerebrovascular diseases (FINNGEN)

234

344

4.82

91.19

1.3

1.2

370.19

741.65

u/l

2.86

225

325

Certain infectious and parasitic diseases

741

1542

2.42

90.98

1.4

1.3

351.10

452.42

u/l

2.05

702

1471

COPD, hospital admissions

624

2160

2.47

90.95

1.3

1.4

593.82

456.80

u/l

0.55

590

2045

Non-allergic asthma (mode)

108

114

9.47

90.77

1.4

1.1

662.74

154.42

u/l

1.35

100

107

Provisional assignment of new diseases of uncertain etiology

584

2343

2.50

90.75

1.4

1.3

439.30

476.94

u/l

0.22

558

2208

COPD, early/later onset

628

2176

2.46

90.53

1.3

1.4

590.61

458.05

u/l

0.53

594

2059

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

217

481

4.62

90.37

1.3

354.46

326.32

u/l

0.25

203

450

Other disorders of fluid, electrolyte and acid-base balance

445

1483

2.87

89.67

1.3

537.58

513.00

u/l

0.06

421

1416

Hypertensive heart and/or renal disease

378

857

3.28

89.13

1.4

1.3

428.78

634.06

u/l

0.54

360

826

Inflammatory bowel disease treatment related agents

969

2568

2.11

88.86

1.4

1.3

492.14

482.40

u/l

0.04

918

2432

Haemorrhage from respiratory passages

422

1286

2.94

87.90

1.4

1.3

322.11

517.86

u/l

2.21

399

1214

Implicit viral Sepsis, including avohilmo

389

1299

3.04

87.80

1.4

1.3

281.54

520.07

u/l

3.37

365

1239

Cardiovascular diseases (excluding rheumatic etc)

297

425

4.02

86.43

1.4

1.2

365.54

791.71

u/l

3.99

278

401

Non-Hodgkin lymphoma, all, including Hilmo

196

417

4.83

85.93

1.3

330.48

309.26

u/l

0.17

183

389

AV-block

244

516

4.12

83.78

1.4

1.3

241.53

734.09

u/l

5.32

239

490

COPD related to multimorbidity

570

1983

2.47

82.97

1.3

598.23

459.74

u/l

0.50

538

1876

Diseases of arteries, arterioles and capillaries

758

2561

2.19

82.06

1.3

321.06

514.74

u/l

3.46

714

2430

Continuous positive airway pressure

201

361

4.71

81.27

1.3

901.61

649.94

u/l

0.30

189

345

Implicit viral Sepsis

291

860

3.45

81.01

1.4

1.3

270.61

386.14

u/l

2.66

276

820

Viral Sepsis

291

860

3.45

81.01

1.4

1.3

270.61

386.14

u/l

2.66

276

820

COPD, hospital admission 2, with asthma infections

490

1644

2.61

80.41

1.3

603.82

420.84

u/l

0.66

462

1557

Primary_lymphoid and hematopoietic malignant neoplasms

357

1204

3.03

79.86

1.4

1.3

346.28

483.09

u/l

1.15

335

1140

COPD, hospital admissions 3, with asthma pneumonia sepsis

444

1428

2.72

78.56

1.3

632.11

400.94

u/l

0.80

418

1352

Conduction disorders

315

772

3.31

78.00

1.4

1.3

250.16

732.02

u/l

7.57

303

738

Valvular operations

192

436

4.50

77.57

1.5

1.3

231.47

808.77

u/l

5.25

181

412

All influenza

254

716

3.59

75.82

1.4

1.3

559.02

374.68

u/l

0.31

232

685

Other arrhythmias

437

1215

2.70

75.16

1.4

1.3

296.45

696.20

u/l

9.82

414

1151

Hypertensive diseases (excluding secondary)

267

404

3.87

74.57

1.4

1.2

394.57

795.10

u/l

3.22

248

382

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

794

2418

2.09

73.77

1.4

1.3

346.52

557.45

u/l

2.71

746

2300

Asthma-related pneumonia

464

1858

2.52

73.61

1.3

632.53

412.55

u/l

0.79

431

1759

Presence of cardiac and vascular implants and grafts

585

1864

2.34

73.60

1.4

1.3

232.43

550.56

u/l

7.56

560

1777

Asthma, hospital admissions 3, pneumonia

464

1862

2.52

73.27

1.3

632.53

411.84

u/l

0.79

431

1763

Asthma-related pneumonia or sepsis

464

1862

2.52

73.27

1.3

632.53

411.84

u/l

0.79

431

1763

Infections, IBD-co-morbidities

190

286

4.74

72.70

1.4

1.2

348.19

690.19

u/l

1.63

178

280

Glomerular diseases

264

790

3.42

72.26

1.4

1.3

293.31

368.91

u/l

1.14

249

753

Cardiomyopathy (excluding other)

169

368

4.70

72.03

1.3

462.82

677.01

u/l

0.32

161

347

Any reimbursement code in KELA

257

319

4.06

71.70

1.4

1.2

347.02

743.65

u/l

1.92

244

299

Pulmonary heart disease, diseases of pulmonary circulation

424

1669

2.58

70.39

1.3

371.57

453.24

u/l

0.76

398

1585

ILD medications: immunosuppressive drugs

517

1999

2.36

70.05

1.4

1.3

452.85

519.24

u/l

0.62

489

1895

Secondary and unspecified malignant neoplasm of lymph nodes

132

239

5.69

69.67

1.4

1.3

330.59

314.55

u/l

0.09

124

224

Cardiomyopathies, Primary/intrinsic

160

345

4.74

69.03

1.3

475.68

755.57

u/l

0.41

152

328

Complications of surgical and medical care, not elsewhere classified

863

2954

1.96

68.55

1.4

1.3

405.14

495.12

u/l

0.65

819

2793

Opioids

708

1700

2.16

68.26

1.3

384.60

528.61

u/l

1.63

673

1598

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

236

386

3.88

68.25

1.4

1.2

406.36

717.45

u/l

2.53

220

365

Polyarthropathies

647

1918

2.18

67.55

1.4

1.3

404.39

519.88

u/l

1.24

605

1830

Tramadol

619

1675

2.24

67.39

1.3

387.37

526.64

u/l

1.41

582

1575

Glomerular disorders in diseases classified elsewhere

195

506

3.97

66.25

1.4

1.3

293.83

345.42

u/l

0.49

184

482

Hypertensive Heart Disease

320

829

2.98

65.24

1.4

1.3

468.77

636.26

u/l

0.34

302

800

Viral pneumonia

155

342

4.62

64.96

1.6

1.3

483.66

299.69

u/l

0.56

150

325

Bleeding

775

2751

1.99

64.79

1.4

1.3

444.94

490.64

u/l

0.23

729

2613

malignant neoplasm of female genital organs, including Hilmo

157

331

4.59

64.47

1.2

1.3

423.84

303.44

u/l

1.50

151

306

Malaise and fatigue

504

1717

2.33

64.39

1.3

463.28

530.17

u/l

0.31

469

1637

General symptoms and signs

783

1940

2.03

64.01

1.3

380.64

517.78

u/l

1.74

734

1848

Malignant neoplasm of breast, HER-positive

217

433

3.77

63.90

1.3

384.71

348.37

u/l

0.15

209

402

Diabetic nephropathy, excluding more controls

233

548

3.55

63.87

1.3

245.72

437.31

u/l

2.07

217

518

Symptoms and signs involving the circulatory and respiratory systems

676

1583

2.15

63.85

1.3

336.00

537.99

u/l

3.24

642

1492

Malignant neoplasm of breast, ER-positive, including Hilmo

217

433

3.76

63.77

1.3

384.71

348.37

u/l

0.15

209

402

Neoplasms

431

865

2.63

63.48

1.4

1.3

377.67

543.21

u/l

1.54

409

812

Malignant neoplasm of breast, HER2-negative

246

453

3.53

63.04

1.3

380.34

343.28

u/l

0.17

238

420

Malignant neoplasm of breast

246

453

3.53

63.02

1.3

380.34

343.28

u/l

0.17

238

420

Iron deficiency anaemia

484

2101

2.28

61.61

1.4

1.3

377.70

482.83

u/l

0.47

453

1997

Metabolic disorders

757

2292

1.99

61.51

1.3

397.87

515.50

u/l

1.11

713

2170

Pulmonary embolism

374

1494

2.54

60.30

1.3

399.73

466.65

u/l

0.50

350

1419

Malignant neoplasm of breast, HER2-negative, including Hilmo

243

456

3.44

59.88

1.3

377.43

342.30

u/l

0.16

235

423

Malignant neoplasm of breast, including Hilmo

243

456

3.44

59.86

1.3

377.43

342.30

u/l

0.16

235

423

Pacemaker

503

2126

2.23

59.56

1.4

1.3

215.27

484.32

u/l

7.65

485

2002

ILD, hospital admissions 3, with pneumonia sepsis

141

311

4.67

59.39

1.4

1.3

502.82

289.80

u/l

2.71

133

294

Pulmonary heart disease

374

1508

2.52

59.14

1.3

399.73

446.95

u/l

0.33

350

1432

Other CVD (FINNGEN)

128

188

5.29

57.00

1.4

1.2

982.18

660.40

u/l

0.33

121

179

Percutaneous Coronary Intervention

661

1992

2.03

56.81

1.4

1.3

361.89

600.46

u/l

2.44

626

1895

Venous thromboembolism

575

2704

2.07

56.79

1.3

468.95

467.43

u/l

0.01

534

2569

Other respiratory disorders and diseases

300

1112

2.75

56.50

1.5

1.3

311.75

388.24

u/l

0.95

279

1051

Other diseases of the respiratory system

300

1112

2.75

56.50

1.5

1.3

311.75

388.24

u/l

0.95

279

1051

ILD, hospital admission 2, with pulmonary infections

146

344

4.35

56.50

1.4

1.2

500.08

301.74

u/l

2.51

137

330

DVT of lower extremities and pulmonary embolism

478

2183

2.21

56.03

1.3

434.98

473.93

u/l

0.25

446

2075

Paroxysmal tachycardia

152

294

4.33

55.94

1.3

1.2

219.34

723.26

u/l

4.50

145

279

Malignant neoplasm of digestive organs, including Hilmo

372

1097

2.52

55.31

1.3

655.51

403.46

u/l

0.61

353

1020

Hypertension, essential

510

1299

2.23

54.56

1.4

1.3

374.67

625.99

u/l

3.39

479

1245

Secondary hypertension

136

6.58

54.53

1.3

1.2

286.25

691.31

u/l

3.00

129

Complications of medical and surgical care

652

3027

1.95

54.12

1.4

1.3

416.68

484.49

u/l

0.33

614

2866

malignant neoplasm of female genital organs

136

305

4.43

53.93

1.2

1.3

423.34

305.86

u/l

1.34

131

283

Chronic lower respiratory diseases

905

2641

1.81

53.90

1.4

1.3

601.77

442.34

u/l

0.90

858

2503

Unspecified kidney failure

180

510

3.63

53.90

1.3

268.48

417.61

u/l

1.04

175

484

Nutritional anaemias

535

2472

2.08

53.87

1.4

1.3

359.32

473.07

u/l

0.60

500

2350

Emergency coronary revascularization (for ACS)

736

2338

1.91

53.33

1.4

1.3

354.19

556.68

u/l

2.29

696

2227

Peripheral artery disease

546

2095

2.08

52.88

1.3

1.4

313.17

527.90

u/l

2.88

509

1992

Cardiovascular diseases

233

367

3.38

52.55

1.4

1.2

365.12

810.03

u/l

3.42

218

345

Coronary revascularization (ANGIO or CABG)

646

1992

1.98

51.99

1.4

1.3

351.12

600.46

u/l

2.59

612

1895

Care involving use of rehabilitation procedures

456

1890

2.18

51.58

1.4

1.3

459.28

552.69

u/l

0.36

426

1773

Insulin medication

569

2364

2.01

51.01

1.4

1.3

311.05

523.84

u/l

3.37

531

2249

Basal cell carcinoma, including Hilmo

381

1086

2.40

50.11

1.3

448.15

405.38

u/l

0.15

364

1010

Complications of procedures, not elsewhere classified

676

2905

1.89

49.96

1.4

1.3

443.29

492.54

u/l

0.23

641

2747

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

386

1105

2.38

49.85

1.3

443.12

403.58

u/l

0.14

369

1029

Other and unspecified iron deficiency

374

1625

2.32

49.83

1.4

1.3

388.91

467.50

u/l

0.24

353

1546

Basal cell carcinoma

372

1061

2.41

49.70

1.3

444.36

399.41

u/l

0.15

354

987

Caries of dentine

256

896

2.79

49.67

1.4

1.3

879.25

417.51

u/l

0.85

243

849

Hypo-osmolality and hyponatraemia

239

835

2.89

49.55

1.3

584.57

401.21

u/l

0.64

226

797

Malignant neoplasm of skin

392

1139

2.35

49.34

1.3

463.96

406.76

u/l

0.21

378

1058

Later onset COPD

420

1525

2.25

49.20

1.3

519.41

388.25

u/l

0.73

395

1440

Hypertensive diseases

498

1309

2.16

49.18

1.4

1.3

374.73

625.13

u/l

3.40

469

1255

Hard cardiovascular diseases

632

1917

1.96

48.97

1.4

1.3

296.82

608.17

u/l

6.72

598

1826

Hypertension

497

1309

2.15

48.83

1.4

1.3

374.80

625.13

u/l

3.40

468

1255

Other malignant neoplasms of skin (=non-melanoma skin cancer)

376

1081

2.38

48.82

1.3

444.31

402.83

u/l

0.14

358

1005

Type 2 diabetes, wide definition

667

2222

1.90

48.31

1.3

310.34

539.82

u/l

5.53

633

2116

Gout

382

1445

2.30

48.14

1.4

1.3

286.32

556.08

u/l

3.34

360

1372

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

149

260

4.09

47.71

1.3

1.2

483.56

695.15

u/l

0.66

139

255

Ischemic heart diseases

646

2012

1.92

47.51

1.4

1.3

298.10

600.15

u/l

6.93

608

1914

Codeine

614

1692

1.97

47.36

1.3

378.57

527.13

u/l

1.69

582

1591

Malignant neoplasm of skin, including Hilmo

395

1163

2.29

47.02

1.3

454.10

406.89

u/l

0.17

379

1081

Asthma, hospital admission 2, infections

523

2579

1.99

46.96

1.3

594.80

449.42

u/l

0.52

483

2451

Asthma-related infections

523

2579

1.99

46.96

1.3

594.80

449.42

u/l

0.52

483

2451

Adjustment and management of implanted device

233

837

2.83

46.66

1.4

1.3

234.15

583.85

u/l

2.83

227

786

Certain infectious and parasitic diseases, including avohilmo

505

1199

2.12

46.34

1.4

1.3

342.25

454.09

u/l

2.00

483

1143

Malignant neoplasm of digestive organs

334

1066

2.42

46.21

1.3

689.06

398.92

u/l

0.64

316

990

Hernia of abdominal wall, postoperative

143

383

3.75

45.68

1.3

1.2

307.17

730.07

u/l

1.51

135

363

Calcific aortic valvular stenosis, operated

411

1855

2.16

45.58

1.4

1.3

316.70

448.45

u/l

0.98

382

1758

Calcific aortic valvular stenosis

411

1855

2.16

45.58

1.4

1.3

316.70

448.45

u/l

0.98

382

1758

Operations 2 for CAVS

411

1855

2.16

45.58

1.4

1.3

316.70

448.45

u/l

0.98

382

1758

Calcific aortic valvular stenosis, diagnosis (helper)

411

1855

2.16

45.58

1.4

1.3

316.70

448.45

u/l

0.98

382

1758

Calcific aortic valvular stenosis, including rheumatic fever

411

1863

2.15

44.95

1.4

1.3

316.70

448.26

u/l

0.98

382

1766

Major coronary heart disease event

671

2179

1.85

44.24

1.4

1.3

298.24

575.25

u/l

6.65

636

2076

Explicit bacterial Sepsis, including avohilmo

149

425

3.58

44.12

1.2

1.3

763.90

376.36

u/l

0.60

135

407

Atherosclerosis, excluding cerebral and coronary sclerosis

509

2024

2.00

44.10

1.3

306.75

529.88

u/l

2.90

474

1926

Autoimmune diseases excluding thyroid diseases, strict definition

777

2389

1.78

43.89

1.4

1.3

423.54

523.91

u/l

1.03

724

2272

Dental caries

269

1004

2.56

43.84

1.4

1.3

846.69

423.44

u/l

0.81

256

950

Morphin

7.42

43.68

1.6

1.3

294.69

294.80

u/l

0.00

Explicit bacterial Sepsis

147

419

3.58

43.59

1.2

1.3

767.11

375.95

u/l

0.59

133

401

Gout, FINNGEN

382

1766

2.18

43.45

1.4

1.3

286.32

541.47

u/l

3.62

360

1676

Oedema, not elsewhere classified

322

1360

2.34

43.43

1.4

1.3

394.20

515.82

u/l

0.53

307

1298

Autoimmune diseases excluding thyroid diseases

796

2467

1.76

43.21

1.4

1.3

417.38

515.45

u/l

1.04

741

2347

Pain in throat and chest

528

1577

1.99

43.00

1.4

1.3

500.13

537.52

u/l

0.12

493

1486

Streptococcal septicaemia, including avohilmo

135

368

3.76

42.86

1.2

1.3

826.37

344.04

u/l

0.70

121

351

Streptococcal septicaemia

133

362

3.76

42.33

1.2

1.3

831.01

345.61

u/l

0.69

119

345

Depression medications

6.85

42.32

1.5

1.3

426.25

877.59

u/l

1.74

Diabetic nephropathy

236

888

2.68

42.25

1.3

243.73

429.16

u/l

1.86

220

836

Coronary atherosclerosis

565

1866

1.92

42.18

1.3

285.03

601.64

u/l

6.76

538

1776

Other diseases of blood and blood-forming organs, wide

241

931

2.63

41.88

1.3

737.76

358.18

u/l

1.01

230

881

STROKE

412

1306

2.14

41.67

1.3

352.09

648.90

u/l

3.96

392

1247

Enterocolitis due to Clostridium difficile

161

503

3.27

41.39

1.4

1.3

267.86

309.43

u/l

0.55

145

477

Hyperkalaemia

111

275

4.17

40.46

1.4

1.3

217.61

355.45

u/l

1.96

106

263

Malignant neoplasm of urinary organs, including Hilmo

135

383

3.59

40.34

1.3

794.26

290.57

u/l

1.08

129

359

Insulin, fast-acting

343

1575

2.20

40.24

1.4

1.3

235.59

489.43

u/l

5.02

318

1499

Insulin, combination of fast acting with intermediate-acting or long-acting

569

2835

1.83

39.38

1.4

1.3

311.05

497.15

u/l

3.09

531

2690

Diabetes, varying definitions

705

2335

1.76

39.08

1.3

320.33

549.66

u/l

5.71

666

2216

Diabetes mellitus

706

2335

1.75

38.77

1.3

319.65

549.76

u/l

5.75

668

2216

Parasetamol

459

1145

2.03

38.17

1.3

367.06

426.20

u/l

0.79

433

1096

Diffuse large B-cell lymphoma

142

5.45

37.91

1.3

434.12

269.18

u/l

1.25

135

Diffuse large B-cell lymphoma, helper endpoint

142

5.45

37.91

1.3

434.12

269.18

u/l

1.25

135

Diffuse large B-cell lymphoma, including Hilmo

142

5.45

37.91

1.3

434.12

269.18

u/l

1.25

135

Malignant neoplasm of urinary organs

120

330

3.71

37.62

1.3

853.79

286.66

u/l

1.09

115

311

Myocardial infarction

467

1685

1.95

37.31

1.3

316.37

596.59

u/l

4.48

443

1602

Enlarged lymph nodes

161

534

3.06

37.29

1.4

359.36

401.22

u/l

0.34

152

511

Major coronary heart disease event excluding revascularizations

545

1951

1.86

37.02

1.4

1.3

295.26

566.72

u/l

5.48

515

1859

Insulin, intermediate and long-acting

510

2675

1.85

36.97

1.4

1.3

264.80

508.76

u/l

6.66

476

2537

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

677

2309

1.75

36.96

1.3

356.62

549.70

u/l

3.22

645

2194

COPD, hospital admissions 1, only main diagnosis

420

1836

1.99

36.68

1.3

529.28

456.34

u/l

0.19

398

1740

Type 2 diabetes

690

2323

1.73

36.00

1.3

323.87

550.36

u/l

5.51

654

2205

Intestinal infectious diseases

706

3116

1.69

35.98

1.4

1.3

381.72

504.38

u/l

2.06

655

2959

Other disorders of skin and subcutaneous tissue

618

3008

1.74

35.88

1.4

1.3

408.23

483.97

u/l

0.61

571

2858

Ulcer of lower limb, not elsewhere classified

204

786

2.64

35.85

1.4

1.3

335.83

339.84

u/l

0.01

194

749

Dipeptidyl peptidase 4 (DPP-4) inhibitors

547

2381

1.82

35.80

1.4

1.3

266.28

508.81

u/l

6.25

508

2267

Diseases of oesophagus, stomach and duodenum

778

2768

1.67

35.79

1.4

1.3

532.11

487.63

u/l

0.19

726

2637

Insulin, fast-acting or short human

345

1663

2.09

35.78

1.4

1.3

239.97

485.97

u/l

5.00

320

1579

Other bacterial intestinal infections

210

826

2.58

35.28

1.4

1.3

319.93

406.81

u/l

0.80

190

777

Cardiomyopathy, other and unspecified

195

4.50

35.06

1.5

1.3

729.93

504.46

u/l

0.16

184

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

117

333

3.58

34.87

1.3

848.33

288.20

u/l

1.04

112

314

COPD-related respiratory insufficiency

179

656

2.79

34.80

1.4

1.3

659.92

381.11

u/l

0.35

168

624

L04AA Selective immunosuppressants

192

733

2.65

34.22

1.5

1.3

414.18

369.01

u/l

0.36

185

698

Gout, idiopatic and unspecified

320

1534

2.12

33.95

1.4

1.3

296.94

513.96

u/l

2.76

302

1460

Cardiodefibrillation

403

2101

1.93

33.39

1.4

1.3

321.67

514.30

u/l

1.67

385

1995

Implicit fungal Sepsis, including avohilmo

246

3.99

33.38

1.5

1.4

261.94

367.48

u/l

1.10

238

Diarrhoea and gastroenteritis of presumed infectious origin

526

2648

1.78

33.33

1.3

392.27

525.46

u/l

1.77

491

2514

Other respiratory diseases principally affecting the interstitium

237

1025

2.35

32.48

1.4

1.3

410.16

412.36

u/l

0.01

224

972

Pure hypercholesterolaemia

597

2195

1.74

32.41

1.3

402.00

501.66

u/l

0.91

568

2080

Bacterial intestinal infections, IBD co-morbidities

207

845

2.48

32.20

1.4

1.3

319.57

385.76

u/l

0.56

187

793

Disorders of lipoprotein metabolism and other lipidaemias

626

2235

1.71

32.02

1.4

1.3

384.16

513.45

u/l

1.38

594

2118

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

505

2814

1.77

31.72

1.4

1.3

462.39

483.61

u/l

0.07

476

2672

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

150

4.87

31.70

1.5

1.3

178.90

266.91

u/l

1.54

142

Diabetes, insulin treatment (Kela reimbursement)

736

2690

1.63

31.61

1.3

364.26

528.01

u/l

2.47

699

2551

Other bacterial intestinal infections, including avohilmo

233

1013

2.33

31.43

1.4

1.3

328.66

404.01

u/l

0.80

210

955

Endocrine, nutritional and metabolic diseases

452

1207

1.90

31.07

1.3

357.62

627.91

u/l

3.18

426

1153

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

172

294

2.95

30.99

1.3

1.2

339.73

450.55

u/l

1.44

163

277

Agranulocytosis

126

405

3.17

30.97

1.3

1.4

827.57

351.87

u/l

0.67

118

389

Infections of the skin and subcutaneous tissue

436

2360

1.83

30.57

1.4

1.3

515.86

525.61

u/l

0.03

417

2233

Persons encountering health services in other circumstances, wide

831

2705

1.58

30.52

1.4

1.3

486.28

476.57

u/l

0.04

790

2561

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

185

736

2.56

30.51

1.5

1.3

723.94

367.63

u/l

0.63

171

705

Type 1 diabetes, wide definition, subgroup 1

160

594

2.72

30.11

1.3

237.29

450.43

u/l

6.03

148

569

807

2583

1.59

29.92

1.3

389.57

467.85

u/l

1.02

760

2456

Non-follicular lymphoma

135

464

2.98

29.66

1.4

347.73

328.86

u/l

0.13

124

440

Diseases of the digestive system

438

2441

1.79

28.86

1.4

1.3

471.12

469.25

u/l

0.00

408

2322

Antihypertensive medication - note that there are other indications

232

508

2.39

28.81

1.4

1.2

328.73

732.13

u/l

4.18

222

477

Diseases of liver

306

1532

2.01

28.80

1.4

1.3

661.79

490.13

u/l

0.40

285

1458

Peripheral arterial reconstruction

235

1072

2.23

28.46

1.4

1.3

351.92

393.82

u/l

0.17

221

1018

Nonischemic cardiomyopathy

128

437

2.98

28.37

1.4

1.3

639.48

365.89

u/l

0.33

120

418

Type 1 diabetes

194

816

2.39

28.13

1.3

245.63

591.38

u/l

3.11

184

777

Asthma/COPD (KELA code 203)

642

2639

1.63

28.13

1.4

1.3

653.95

432.77

u/l

0.93

608

2501

Other acute lower respiratory infections

445

2404

1.77

28.09

1.4

1.3

526.55

480.89

u/l

0.20

414

2282

Amputation

147

545

2.75

28.02

1.4

1.3

382.90

409.85

u/l

0.06

138

518

Abnormal findings on examination of blood, without diagnosis

456

2359

1.76

27.87

1.3

382.86

512.61

u/l

1.46

426

2232

Iron deficiency anaemia secondary to blood loss (chronic)

179

739

2.46

27.28

1.4

1.3

295.32

389.93

u/l

0.70

164

696

Ischaemic heart disease, wide definition

589

2192

1.66

27.24

1.4

1.3

310.40

557.07

u/l

5.44

557

2080

Bronchitis

779

3018

1.55

27.24

1.3

419.31

487.49

u/l

0.72

729

2862

Early onset COPD

218

982

2.25

27.15

1.3

708.27

436.63

u/l

0.45

209

936

Gout, unspecified

256

1234

2.10

26.92

1.4

1.3

290.25

502.85

u/l

2.05

242

1174

Syncope and collapse

368

1659

1.86

26.76

1.3

416.63

531.80

u/l

0.37

341

1578

Gout, strict definition

239

1126

2.16

26.71

1.4

1.3

241.67

480.75

u/l

2.64

224

1070

Vocal cord dysfunction

100

264

3.36

26.56

1.4

1.2

329.72

709.61

u/l

2.05

259

Cough

277

1280

2.03

26.51

1.4

1.3

435.91

550.78

u/l

0.61

266

1212

Cerebrovascular diseases

633

2743

1.61

26.35

1.3

331.78

505.09

u/l

3.49

601

2606

Fall on same level

746

2559

1.56

25.90

1.3

586.14

455.99

u/l

0.56

704

2425

Disorders resulting from impaired renal tubular function

139

4.62

25.87

1.3

1.4

184.29

382.48

u/l

1.81

134

Myocardial infarction, strict

411

1631

1.80

25.73

1.3

402.80

606.29

u/l

1.09

390

1550

GI-bleeding

344

1868

1.86

25.48

1.4

1.3

519.90

468.01

u/l

0.12

320

1774

Substance abuse, excluding more controls

439

2121

1.74

25.43

1.3

790.69

464.78

u/l

1.37

410

2015

Type 2 diabetes, definitions combined

634

2306

1.61

25.39

1.3

333.73

550.66

u/l

4.94

599

2189

Amputation of toe

110

370

3.05

25.22

1.4

404.12

346.37

u/l

0.13

105

350

Diabetes medication

697

2608

1.57

25.19

1.3

352.95

534.27

u/l

3.08

660

2476

Type 2 diabetes, strict (exclude DM1)

638

2329

1.60

25.18

1.3

337.47

548.20

u/l

4.74

602

2209

Used for control exclusion in common control thyroid runs

708

2282

1.57

25.02

1.4

1.3

468.69

530.87

u/l

0.31

667

2168

Symptoms and signs involving the urinary system

600

2839

1.60

24.95

1.4

1.3

507.85

462.70

u/l

0.19

558

2699

Type 1 diabetes, wide definition

164

677

2.44

24.88

1.3

243.73

428.22

u/l

4.98

152

644

Other diseases of the digestive system

340

1854

1.85

24.88

1.4

1.3

523.08

464.56

u/l

0.13

316

1760

Use of hypnotics and sedatives

743

2767

1.54

24.81

1.3

525.95

491.38

u/l

0.16

705

2617

Peripheral artery operations in Hilmo

163

685

2.42

23.97

1.3

420.13

456.51

u/l

0.10

153

652

Factors influencing health status and contact with health services

199

425

2.36

23.81

1.3

1.2

381.09

509.81

u/l

0.71

188

400

ILD, hospital admissions

191

863

2.25

23.78

1.4

1.3

457.21

370.31

u/l

0.67

179

818

Autoimmune diseases

744

2471

1.53

23.78

1.4

1.3

464.04

515.28

u/l

0.26

697

2351

Injuries to the head

759

2983

1.51

23.69

1.3

524.87

467.61

u/l

0.26

719

2825

Other interstitial pulmonary diseases

193

878

2.23

23.63

1.4

1.3

455.86

370.77

u/l

0.66

180

830

Pleural plaque with presence of asbestos

132

508

2.67

23.63

1.4

395.11

338.00

u/l

0.63

126

478

Osteopathies and chondropathies

431

2326

1.70

23.54

1.3

339.84

502.64

u/l

2.31

403

2216

Persons encountering health services for other counselling and medical advice, not elsewhere classified

763

2680

1.52

23.52

1.4

1.3

536.39

477.18

u/l

0.26

730

2537

460

2467

1.67

23.48

1.3

674.67

501.95

u/l

0.65

427

2340

Purpura and other haemorrhagic conditions

140

554

2.56

23.43

1.3

1.4

398.13

339.07

u/l

0.51

132

528

Coagulation defects, purpura and other haemorrhagic conditions

180

797

2.28

23.42

1.3

380.80

342.35

u/l

0.37

169

759

Interstitial lung disease

193

884

2.22

23.25

1.4

1.3

455.86

367.97

u/l

0.70

180

838

Interstitial lung disease endpoints

193

884

2.22

23.25

1.4

1.3

455.86

367.97

u/l

0.70

180

838

Mental and behavioural disorders due to psychoactive substance use

452

2490

1.67

23.04

1.3

778.33

475.40

u/l

1.30

423

2356

Glomerulonephritis

106

367

2.94

23.03

1.4

1.3

327.11

353.85

u/l

0.17

349

Type 2 diabetes, definitions combined, including avohilmo

624

2302

1.57

22.97

1.3

341.41

550.54

u/l

4.58

590

2182

Disorders of choroid and retina

646

2937

1.55

22.88

1.3

455.99

471.80

u/l

0.06

620

2777

Hyperlipidaemia, other/unspecified

361

1839

1.78

22.84

1.4

1.3

264.14

486.70

u/l

4.53

335

1747

Medicines for HER+ breast cancer

232

1063

2.05

22.73

1.3

374.12

392.28

u/l

0.08

224

1011

Colorectal cancer, including Hilmo

206

905

2.14

22.64

1.3

634.50

393.67

u/l

0.35

196

844

Gastroduodenal ulcer

285

1511

1.90

22.63

1.3

444.55

447.79

u/l

0.01

268

1450

Substance abuse

439

2451

1.67

22.52

1.3

790.69

478.88

u/l

1.30

410

2320

Codeine or tramadol medication

766

2783

1.50

22.47

1.3

444.38

501.99

u/l

0.35

726

2639

Drug-induced neutropenia

254

3.33

22.29

1.3

1.4

479.21

361.70

u/l

0.67

245

Asthma (diagnoses ohter than nonallergic)

609

3189

1.55

22.25

1.4

1.3

574.93

455.35

u/l

0.47

569

3025

Hypokalaemia

124

475

2.65

22.21

1.4

1.3

671.74

357.82

u/l

0.39

118

454

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

450

2739

1.65

22.02

1.3

430.34

482.79

u/l

0.18

423

2601

469

2503

1.64

21.97

1.3

666.65

499.65

u/l

0.63

435

2374

Alcohol use disorder, Swedish definition

435

2398

1.66

21.50

1.3

677.72

497.98

u/l

0.64

404

2277

Other soft tissue disorders, not elsewhere classified

634

2345

1.54

21.45

1.3

398.31

503.94

u/l

1.33

590

2221

Lung transplantation

19.88

21.44

1.5

1.3

298.26

350.42

u/l

0.19

Disorders of lens

507

1950

1.62

21.43

1.4

1.3

333.22

488.19

u/l

2.86

480

1847

All influenza (not pneumonia)

301

3.05

21.35

1.4

1.3

285.50

329.18

u/l

0.45

288

Stroke, including SAH

558

2561

1.57

21.35

1.3

322.86

508.63

u/l

3.53

526

2431

Reimbursement for rheumatic diseases

397

2350

1.69

21.33

1.4

1.3

483.20

485.67

u/l

0.01

373

2234

Diabetic retinopathy, excluding more controls

227

612

2.09

21.10

1.3

429.25

434.52

u/l

0.01

219

581

Volume depletion

119

459

2.63

21.08

1.4

1.3

255.06

410.66

u/l

0.96

112

434

Need for other prophylactic measures

190

3.65

21.04

1.3

469.09

367.10

u/l

0.42

182

Other disorders of kidney and ureter

143

603

2.41

20.96

1.3

1.4

283.37

343.89

u/l

0.70

133

575

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

692

2928

1.50

20.91

1.4

1.3

514.48

479.20

u/l

0.15

651

2774

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

350

2.88

20.79

1.4

388.71

326.17

u/l

0.42

333

Unspecified acute lower respiratory infection

145

619

2.37

20.63

1.3

530.35

370.42

u/l

0.78

134

584

Other retinal disorders

553

2709

1.56

20.62

1.3

300.89

467.44

u/l

2.87

528

2559

Lung transplant status

19.20

20.55

1.5

1.3

296.21

350.42

u/l

0.19

Disorders of gallbladder, biliary tract and pancreas

704

2958

1.49

20.36

1.4

1.3

444.38

498.19

u/l

0.26

671

2801

Other CVD

232

1196

1.96

20.34

1.3

639.39

385.43

u/l

0.52

220

1133

Pain in limb

566

2322

1.55

20.27

1.3

384.38

489.98

u/l

1.42

525

2199

ILD, hospital admissions 1, main diag only

168

771

2.21

20.23

1.4

1.3

468.44

333.58

u/l

1.59

156

730

Coronary artery bypass grafting

280

1124

1.87

20.03

1.3

261.27

643.35

u/l

4.38

265

1069

Misadventures to patients during surgical and medical care

137

579

2.39

19.97

1.5

1.3

398.63

339.03

u/l

0.14

128

551

Symptoms and signs involving the digestive system and abdomen

676

2261

1.50

19.79

1.4

1.3

429.62

532.44

u/l

0.69

636

2144

Lymphoid leukaemia

248

3.22

19.78

1.5

1.4

359.70

364.60

u/l

0.02

239

Other diseases of intestines

663

2469

1.50

19.69

1.3

416.64

514.93

u/l

1.10

627

2338

Pneumococcal septicemia

118

4.36

19.60

1.3

772.96

433.35

u/l

0.88

113

Idiopathic gout

129

537

2.45

19.57

1.4

1.3

351.94

369.00

u/l

0.09

119

509

Pain, not elsewhere classified

189

918

2.07

19.50

1.3

700.97

495.80

u/l

0.63

179

880

Rheumatoid arthritis

273

1322

1.84

19.49

1.4

1.3

559.62

512.05

u/l

0.23

257

1267

Hydronephrosis

114

449

2.57

19.36

1.3

519.00

331.98

u/l

0.71

103

430

Intestinal infectious diseases, including avohilmo, including avohilmo

783

3032

1.44

19.08

1.3

404.42

502.16

u/l

1.30

726

2882

L04AX Other immunosuppressants

367

2208

1.67

19.02

1.4

1.3

533.41

477.88

u/l

0.43

346

2099

L02BG Aromatase inhibitors

197

970

2.02

18.91

1.3

390.02

373.67

u/l

0.06

191

925

Benign neoplasm of colon, rectum, anus and anal canal

536

2972

1.53

18.89

1.4

1.3

471.04

470.86

u/l

0.00

506

2815

Stroke, excluding SAH

533

2519

1.53

18.47

1.3

325.41

498.33

u/l

3.05

497

2392

Myocardial infarction, without ST-elevation

419

2366

1.61

18.43

1.3

368.25

484.79

u/l

0.57

396

2247

Nausea and vomiting

216

1094

1.94

18.41

1.3

266.57

400.47

u/l

2.71

203

1037

Viral pneumonia (unknown virus, not influenza)

193

3.42

18.35

1.6

1.4

704.25

368.98

u/l

0.41

188

Colorectal cancer

180

842

2.07

18.30

1.3

674.41

339.25

u/l

0.45

170

786

Second line medication for Crohn's disease

370

2253

1.65

18.28

1.4

1.3

531.20

475.20

u/l

0.45

349

2141

Seropositive rheumatoid arthritis

211

1087

1.95

18.23

1.4

1.3

591.61

413.85

u/l

1.65

199

1030

Abnormalities of heart beat

231

1195

1.88

18.12

1.4

1.2

235.88

552.20

u/l

4.56

224

1127

Rheumatoid arthritis, including avohilmo

291

1670

1.75

18.08

1.4

1.3

547.28

384.96

u/l

2.01

273

1583

Retention of urine

353

1712

1.68

18.07

1.3

599.75

495.94

u/l

0.32

330

1625

Open wound of head

433

2583

1.58

17.92

1.3

489.53

470.29

u/l

0.07

412

2446

Other (not insulin) diabetes medications

647

2591

1.47

17.65

1.3

375.44

534.03

u/l

2.30

613

2459

Unspecified haematuria

392

1981

1.62

17.55

1.4

1.3

442.07

487.07

u/l

0.15

364

1877

Dilated cardiomyopathy

139

628

2.25

17.48

1.3

521.93

367.95

u/l

0.19

132

598

Senile cataract

483

1892

1.56

17.46

1.4

1.3

335.31

487.26

u/l

2.62

457

1793

Ischaemic Stroke, excluding all haemorrhages

513

2486

1.53

17.45

1.3

307.02

501.34

u/l

3.72

478

2367

Mental and behavioural disorders due to alcohol, excluding acute intoxication

341

2048

1.66

17.31

1.3

792.41

484.38

u/l

1.00

319

1949

Mental and behavioural disorders due to alcohol

383

2273

1.61

17.25

1.3

754.31

479.61

u/l

0.99

358

2154

Bronchiectasis

321

2.76

16.94

1.6

1.3

717.55

344.25

u/l

0.93

305

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

206

1088

1.91

16.86

1.4

1.3

601.89

342.86

u/l

3.73

194

1034

Convulsions, not elsewhere classified

158

750

2.09

16.82

1.4

1.3

821.90

524.10

u/l

0.40

148

719

Alcoholic liver disease

107

441

2.46

16.61

1.4

1.3

1136.17

369.53

u/l

0.82

418

Seropositive rheumatoid arthritis, wide

211

1134

1.88

16.38

1.4

1.3

591.61

344.15

u/l

3.60

199

1075

Persons with potential health hazards related to communicable diseases

171

849

2.00

16.24

1.3

646.73

408.13

u/l

0.39

155

809

Acute bronchitis

326

1947

1.65

16.24

1.4

1.3

517.93

444.08

u/l

0.29

304

1852

Other/unspecified seropositive rheumatoid arthritis

208

1119

1.87

16.11

1.4

1.3

596.96

343.78

u/l

3.66

196

1060

Constipation

635

2996

1.44

16.06

1.3

555.49

469.95

u/l

0.46

593

2848

Fracture of femur

285

1511

1.71

16.05

1.2

1.3

601.49

390.01

u/l

0.53

268

1431

Thrombocytopenia, unspecified

287

2.80

15.86

1.3

351.29

362.86

u/l

0.07

276

Intracranial trauma

355

1479

1.63

15.75

1.3

409.55

525.90

u/l

1.07

332

1417

Diseases of the skin and subcutaneous tissue

628

2175

1.45

15.71

1.3

360.43

515.41

u/l

2.59

592

2061

Emphysema

352

2.60

15.65

1.3

425.02

346.03

u/l

0.55

332

Chylothorax

40.45

15.62

1.7

1.2

166.53

218.67

u/l

—

Osteoporosis

233

1200

1.80

15.59

1.4

1.3

341.93

337.31

u/l

0.03

219

1135

Alcohol use disorder, ICD-based

312

1902

1.65

15.57

1.3

789.72

478.90

u/l

0.91

291

1809

Diabetic maculopathy, excluding more controls

394

2.49

15.54

1.4

1.3

193.79

384.61

u/l

4.42

381

Intestinal stricture

275

1631

1.70

15.29

1.3

440.52

442.45

u/l

0.01

254

1556

Presence of other functional implants

463

2099

1.52

15.20

1.3

400.53

550.08

u/l

0.74

430

2001

Hypotension

196

1060

1.87

15.02

1.3

717.64

373.01

u/l

0.63

186

998

Benign neoplasm: Colon

457

2873

1.50

14.95

1.4

1.3

360.47

486.87

u/l

1.41

429

2726

Disorders of thyroid, IBD co-morbidities

104

292

2.45

14.92

1.4

1.2

387.32

668.70

u/l

1.08

284

Paralytic ileus and intestinal obstruction

236

1351

1.76

14.88

1.3

470.53

484.21

u/l

0.04

220

1293

Polyneuropathies and other disorders of the peripheral nervous system

209

1158

1.82

14.81

1.3

315.22

471.40

u/l

1.35

201

1097

Fitting and adjustment of other devices

273

1428

1.69

14.78

1.4

1.3

302.96

515.80

u/l

2.61

264

1341

Cutaneous abscess, furuncle and carbuncle

183

973

1.89

14.73

1.4

1.3

405.16

391.48

u/l

0.09

176

929

Other arthritis (FG)

224

1274

1.77

14.48

1.4

1.3

357.60

549.28

u/l

1.54

210

1212

Biguanides

630

2689

1.42

14.43

1.3

399.86

518.78

u/l

1.32

593

2551

Osteomyelitis

280

2.73

14.35

1.3

1.4

285.46

370.55

u/l

0.67

269

Problems related to lifestyle

275

2.72

14.21

1.3

394.18

455.68

u/l

0.38

264

Malignant neoplasm of colon, including Hilmo

138

672

2.06

14.16

1.3

308.52

307.99

u/l

0.00

132

626

In situ neoplasms

321

2021

1.60

14.11

1.4

1.3

519.42

434.08

u/l

0.17

308

1911

Fracture of rib(s), sternum and thoracic spine

272

1646

1.66

14.06

1.3

546.61

494.81

u/l

0.17

262

1559

Other specified/unspecified arthritis

204

1140

1.80

14.03

1.4

1.3

361.18

557.69

u/l

1.46

190

1095

Other cataract

351

1661

1.58

14.02

1.3

512.37

490.31

u/l

0.04

338

1578

Cellulitis

174

926

1.89

14.01

1.4

1.3

711.61

371.45

u/l

0.68

168

885

Injuries to the abdomen, lower back, lumbar spine and pelvis

314

1940

1.60

14.01

1.4

1.3

709.46

430.90

u/l

0.84

298

1840

Hernia

605

2848

1.41

13.96

1.3

474.90

474.82

u/l

0.00

574

2702

Finngen Rheumatological endpoints

571

2264

1.43

13.83

1.3

359.10

544.85

u/l

3.12

537

2146

Diagnoses used for exclusion with ILD

224

1300

1.74

13.56

1.5

1.3

326.83

397.26

u/l

0.83

213

1229

Injuries to the hip and thigh

407

2436

1.50

13.52

1.3

530.94

470.78

u/l

0.17

386

2312

Gastric ulcer

174

938

1.87

13.51

1.4

1.3

260.36

347.05

u/l

1.96

162

898

272

1652

1.64

13.38

1.3

458.46

406.42

u/l

0.48

251

1566

Duodenal ulcer

126

611

2.09

13.34

1.3

664.25

334.80

u/l

0.42

120

585

Sub-endpoint used in defining T1D endpoints

213

1203

1.75

13.34

1.3

234.50

412.92

u/l

4.12

199

1143

Sulfasalazine

177

963

1.85

13.30

1.4

1.3

542.40

412.17

u/l

1.20

166

916

Other special examinations and investigations of persons without complaint or reported diagnosis

418

1396

1.52

13.24

1.4

1.3

336.90

482.41

u/l

2.30

397

1326

Fracture of lumbar spine and pelvis

209

1195

1.76

13.24

1.4

1.3

707.89

374.36

u/l

0.69

195

1134

Angina pectoris

405

1782

1.51

13.21

1.4

1.3

321.67

602.22

u/l

4.86

380

1696

Other/unspecified rheumatoid arthritis

108

495

2.21

13.20

1.4

544.74

321.23

u/l

1.41

103

471

Lung diseases due to external agents

151

786

1.94

13.09

1.4

1.3

366.65

369.42

u/l

0.01

143

741

Other and unspecified polyneuropathies, also in other diseases

185

1028

1.82

13.06

1.3

305.00

442.45

u/l

1.14

178

973

Benign neoplasms

604

2342

1.41

13.04

1.4

1.3

358.59

539.07

u/l

3.72

573

2222

Viral infections characterized by skin and mucous membrane lesions

277

1730

1.61

12.59

1.3

396.67

442.08

u/l

0.33

257

1647

Exposure to unspecified factor

642

3184

1.37

12.59

1.3

565.91

466.03

u/l

0.47

614

3006

Symptoms and signs concerning food and fluid intake

409

2.29

12.50

1.3

1.4

739.50

374.39

u/l

0.66

392

Persons encountering health services in other circumstances

258

1575

1.63

12.35

1.4

1.3

320.45

508.97

u/l

2.77

246

1498

Sequelae of external causes of morbidity and mortality

203

1182

1.73

12.20

1.4

1.3

406.26

364.13

u/l

0.21

189

1122

Fentanyl

100

459

2.20

12.15

1.4

326.78

401.80

u/l

0.36

100

432

Medical observation and evaluation for suspected diseases and conditions

408

1396

1.50

12.11

1.4

1.3

394.01

482.41

u/l

0.94

393

1326

Genitourinary diseases

339

1092

1.56

12.10

1.3

340.17

647.48

u/l

4.35

320

1050

Falls/tendency to fall

620

2247

1.38

12.07

1.3

416.81

451.01

u/l

0.19

581

2133

Seropositive rheumatoid arthritis, strict definition

114

553

2.08

12.07

1.4

1.3

645.84

353.18

u/l

2.79

106

524

Malignant neoplasm of bladder, including Hilmo

109

513

2.12

12.06

1.3

306.21

285.86

u/l

0.21

104

475

Other disorders of skin and subcutaneous tissue, not elsewhere classified

123

620

2.00

11.74

1.4

1.3

333.30

328.03

u/l

0.02

117

591

Dermatitis

419

2841

1.45

11.68

1.4

1.3

387.58

504.78

u/l

1.36

399

2699

Substance use, excluding alcohol

113

553

2.06

11.67

1.3

1421.23

399.86

u/l

1.35

107

533

Benzodiazepine use

642

3201

1.36

11.64

1.3

566.70

465.15

u/l

0.52

598

3038

Chronic apical periodontitis

699

2920

1.34

11.61

1.3

553.50

460.37

u/l

0.48

668

2759

N06DA Anticholinesterases

154

2110

0.56

11.60

1.3

362.84

431.44

u/l

0.56

138

2001

Use of anticholinesterases

154

2110

0.56

11.60

1.3

362.84

431.44

u/l

0.56

138

2001

Cardiomyopathy in other diseases

13.75

11.38

1.6

1.5

121.68

302.60

u/l

1.74

Autoimmune diseases related-to ILD

519

3125

1.39

11.32

1.3

513.62

482.02

u/l

0.11

475

2973

Injuries to the thorax

357

2423

1.48

11.17

1.3

493.56

508.90

u/l

0.06

345

2289

Malignant neoplasm of other connective and soft tissue, including Hilmo

106

3.55

11.17

1.2

1.3

361.63

392.27

u/l

0.09

101

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

276

2.49

11.06

1.6

1.3

193.01

362.29

u/l

3.29

266

Diabetic retinopathy

297

1188

1.56

11.05

1.3

376.44

373.74

u/l

0.01

284

1114

Colorectal adenocarcinoma

143

764

1.86

11.01

1.2

1.3

318.47

341.29

u/l

0.16

135

712

Other gastritis (incl. Duodenitis)

181

1053

1.73

10.98

1.5

1.3

307.39

390.48

u/l

1.38

158

1013

Malignant neoplasm of colon

112

561

2.01

10.90

1.3

302.64

323.23

u/l

0.18

106

520

Decubitus ulcer and pressure area

315

2.39

10.89

1.2

1.4

447.40

358.40

u/l

0.27

306

Other (seronegative) rheumatoid arthritis, wide

143

778

1.85

10.89

1.3

530.52

330.96

u/l

1.72

135

731

Certain disorders involving the immune mechanism

132

701

1.90

10.83

1.6

1.3

335.07

367.45

u/l

0.27

127

667

Chronic periodontitis, including avohilmo

634

3015

1.34

10.79

1.3

495.70

485.62

u/l

0.05

599

2855

Periodontitis

634

3013

1.34

10.76

1.3

495.65

485.73

u/l

0.05

599

2852

Mycoses

201

1210

1.67

10.74

1.3

371.21

373.13

u/l

0.01

186

1144

Other or unspecified ileus, impaction or obstruction

166

949

1.76

10.71

1.3

337.67

466.56

u/l

0.83

153

906

Other and unspecified dermatitis

344

2341

1.47

10.67

1.4

1.3

353.02

519.61

u/l

2.54

327

2227

Chronic pancreatitis

109

549

2.01

10.50

1.4

1.3

951.64

376.76

u/l

0.67

104

523

General examination and investigation of persons without complaint and reported diagnosis

391

1391

1.46

10.47

1.4

1.3

369.40

483.28

u/l

1.44

370

1321

Open wound of lower leg

112

572

1.97

10.35

1.4

1.3

363.45

331.89

u/l

0.19

100

547

Other external causes of accidental injury

480

1716

1.40

10.25

1.3

345.95

448.73

u/l

1.72

448

1624

Acute pancreatitis

158

905

1.76

10.17

1.4

1.3

774.95

432.53

u/l

0.50

143

856

Malignant melanoma, including Hilmo

112

577

1.95

10.10

1.4

1.3

349.88

313.81

u/l

0.27

112

541

Diverticular disease of intestine

509

2308

1.38

10.07

1.3

365.14

498.13

u/l

1.71

480

2190

Discitis, unspecified

4.16

10.05

1.1

1.4

2413.86

284.27

u/l

0.52

Asthma and opportunity respiratory infection

195

2.72

10.00

1.5

1.3

612.26

348.81

u/l

1.07

189

Concussion

288

1476

1.52

9.94

1.3

482.82

526.37

u/l

0.17

269

1414

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

627

3032

1.33

9.92

1.3

434.79

500.91

u/l

0.65

583

2882

Other infectious diseases, including avohilmo

382

2.17

9.76

1.4

1.3

589.19

335.28

u/l

0.53

365

Malignant melanoma

101

509

2.00

9.72

1.4

1.3

366.85

318.36

u/l

0.35

101

477

Candidiasis, including avohilmo

176

1061

1.67

9.41

1.4

1.3

357.66

373.82

u/l

0.12

166

1010

Accidents

473

1716

1.38

9.33

1.3

336.64

448.73

u/l

1.98

442

1624

Mental and behavioural disorders due to use of other stimulants, including caffeine

8.75

9.30

1.4

1.1

4585.79

723.75

u/l

0.81

Disorders of mineral metabolism

312

2.27

9.29

1.4

1.3

879.07

352.55

u/l

0.60

302

Elevated blood glucose level

306

2.28

9.27

1.2

1.4

449.96

340.97

u/l

0.46

292

Unstable angina pectoris

300

1599

1.48

9.23

1.4

1.3

313.40

590.70

u/l

4.02

278

1524

Gastrointestinal diseases

270

881

1.54

9.22

1.4

1.3

356.60

435.82

u/l

1.38

259

839

Examination and observation for other reasons

352

1374

1.45

9.20

1.3

752.24

485.80

u/l

0.58

332

1306

Status post-ami

234

1143

1.56

9.18

1.3

288.80

572.00

u/l

3.29

218

1089

Abnormal results of function studies

252

2.40

9.12

1.5

1.3

345.17

359.55

u/l

0.07

246

Asthma, hospital admissions , main diagnosis only

489

3155

1.35

9.11

1.4

1.3

416.76

489.06

u/l

0.65

452

2997

Symptoms and signs involving cognition, perception, emotional state and behaviour

597

3031

1.32

9.07

1.3

475.48

482.08

u/l

0.02

554

2885

Vascular disorders of the intestines

355

2.17

9.03

1.4

1.3

269.88

307.41

u/l

0.31

341

Sequelae with surgical and medical care as external cause

158

943

1.69

8.84

1.4

1.3

376.11

361.42

u/l

0.06

150

893

Phlebitis and thrombophlebitis (not including DVT)

160

961

1.67

8.73

1.3

521.91

395.55

u/l

0.45

145

910

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

393

2.08

8.72

1.3

1.4

580.37

351.58

u/l

0.37

373

Other antidepressants

659

2589

1.30

8.72

1.4

1.3

527.36

458.07

u/l

0.34

617

2459

Cholelithiasis, broad definition with cholecystitis

565

2854

1.32

8.69

1.3

454.45

494.46

u/l

0.15

534

2703

Disorders of other endocrine glands

257

1700

1.49

8.58

1.3

311.28

377.67

u/l

1.27

238

1612

Abdominal and pelvic pain

592

2261

1.32

8.53

1.4

1.3

446.06

532.44

u/l

0.48

559

2144

Obesity related asthma

213

1380

1.55

8.50

1.4

1.3

733.41

412.50

u/l

0.52

199

1314

Small cell lung cancer, helper endpoint

149

2.82

8.46

1.2

1.3

416.80

311.94

u/l

0.50

141

Persons encountering health services for examination and investigation

389

1396

1.40

8.31

1.4

1.3

369.99

482.41

u/l

1.29

369

1326

Unspecified fall

350

2462

1.40

8.29

1.3

702.14

453.26

u/l

0.69

333

2338

Other diseases of arteries and capillaries

341

2.13

8.28

1.3

1.4

221.63

369.91

u/l

2.49

324

Other and unspecified local infections of skin and subcutaneous tissue

344

2.11

8.10

1.4

1.3

355.89

356.25

u/l

0.00

329

Intracranial injury

383

2607

1.37

8.04

1.3

426.26

465.71

u/l

0.20

360

2472

Thyrotoxicosis

146

879

1.67

7.94

1.4

1.3

309.56

370.17

u/l

0.50

136

833

Aortic aneurysm

221

1441

1.51

7.87

1.3

357.30

534.56

u/l

1.69

209

1377

Other nutritional deficiencies

354

2339

1.38

7.86

1.3

521.66

480.34

u/l

0.11

332

2224

Other functional intestinal disorders

312

2010

1.41

7.81

1.3

632.49

507.74

u/l

0.38

289

1914

Other symptoms and signs involving the urinary system

501

1.89

7.80

1.5

1.3

297.53

366.61

u/l

0.72

478

malignant neoplasm of male genital organs

197

757

1.57

7.77

1.4

453.46

449.93

u/l

0.01

184

706

Acute pancreatitis (for exclusion)

158

977

1.63

7.76

1.4

1.3

774.95

407.70

u/l

0.56

143

931

Other local infections of skin and subcutaneous tissue

377

2.03

7.75

1.4

1.3

365.24

352.35

u/l

0.07

361

Systemic connective tissue disorders

232

1569

1.48

7.62

1.3

458.81

391.15

u/l

0.32

217

1486

Soft tissue disorders

595

2359

1.29

7.62

1.4

1.3

337.87

502.29

u/l

3.20

556

2235

Malignant melanoma of skin

366

2.04

7.61

1.4

1.3

387.68

331.84

u/l

0.32

342

Injury, poisoning and certain other consequences of external causes

297

1032

1.45

7.60

1.4

1.3

350.94

427.56

u/l

0.77

282

975

Chronic periodontitis, complicated

373

2673

1.36

7.60

1.3

524.50

480.66

u/l

0.18

353

2545

Tuberculosis, IBD comorbidity

340

2.08

7.59

1.5

1.3

414.04

284.25

u/l

1.29

325

malignant neoplasm of male genital organs, including Hilmo

198

764

1.56

7.59

1.4

1.3

457.57

459.29

u/l

0.00

184

713

Congenital malformations, deformations and chromosomal abnormalities

270

1780

1.44

7.57

1.4

1.3

455.64

462.78

u/l

0.02

261

1686

Other noninfective gastroenteritis and colitis

155

960

1.62

7.54

1.3

604.79

350.52

u/l

0.65

138

911

Zoster [herpes zoster]

147

901

1.64

7.50

1.4

1.3

287.78

342.66

u/l

0.90

137

852

Other symptoms and signs involving the digestive system and abdomen

101

560

1.81

7.39

1.4

1.3

385.31

371.71

u/l

0.08

532

Malignant melanoma of skin, including Hilmo

461

1.90

7.35

1.4

1.3

358.10

306.70

u/l

0.35

430

Corns and callosities

246

2.26

7.34

1.3

299.83

352.43

u/l

0.35

236

Thyrotoxicosis, other and/or unspecified

113

649

1.75

7.34

1.4

1.3

252.74

397.10

u/l

2.43

104

615

Diabetic retinopathy, strict definition

135

721

1.67

7.30

1.3

193.42

396.04

u/l

5.08

127

678

Asthma, including avohilmo

705

3093

1.26

7.27

1.4

1.3

628.29

452.74

u/l

0.86

664

2930

Supplementary factors related to causes of morbidity and mortality classified elsewhere

193

1270

1.53

7.26

1.4

1.3

622.79

368.00

u/l

0.51

179

1202

Respiratory tuberculosis, confirmed and not-confirmed

267

2.20

7.24

1.5

1.3

437.20

319.13

u/l

0.86

254

Respiratory tuberculosis

267

2.20

7.24

1.5

1.3

437.20

319.13

u/l

0.86

254

Cholecystitis

119

701

1.71

7.10

1.3

881.13

395.27

u/l

0.58

111

660

Other infectious diseases

322

2.07

7.10

1.4

1.3

337.68

351.54

u/l

0.08

309

Tuberculosis

309

2.10

7.09

1.5

1.3

413.44

306.17

u/l

0.86

295

Left ventricular outflow tract obstruction, narrow definition

123

2.79

7.07

1.4

278.70

399.70

u/l

0.67

117

Pain (limb, back, neck, head abdominally)

449

1694

1.33

7.05

1.4

1.3

423.57

550.71

u/l

0.62

422

1610

External causes of morbidity and mortality

351

1276

1.38

7.00

1.4

1.3

339.85

463.93

u/l

1.71

334

1209

Poisoning by drugs, medicaments and biological substances

106

607

1.75

6.97

1.3

576.33

395.58

u/l

1.57

583

Other viral diseases

136

830

1.64

6.96

1.4

1.3

418.92

390.61

u/l

0.16

127

797

Unspecific neurodegenerative disorder

225

2220

0.69

6.85

1.2

1.3

397.06

422.92

u/l

0.12

209

2107

Alcohol dependence

184

1217

1.52

6.80

1.3

1005.01

501.40

u/l

0.92

171

1163

Type of accident

180

1185

1.53

6.79

1.4

1.3

643.42

371.70

u/l

0.51

168

1123

Malignant neoplasm of prostate

192

745

1.53

6.77

1.4

1.3

458.87

448.39

u/l

0.02

179

694

Chronic diseases of tonsils and adenoids

210

1929

0.68

6.69

1.3

484.07

507.08

u/l

0.10

199

1842

Tuberculosis, wide

358

1.98

6.64

1.5

1.3

414.04

402.27

u/l

0.03

343

Other skin changes

153

978

1.57

6.62

1.4

1.3

471.65

385.31

u/l

0.30

146

924

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

285

2.09

6.53

1.4

1.3

313.58

357.17

u/l

0.30

278

Tuberculosis, wide, including avohilmo

361

1.96

6.49

1.5

1.3

414.04

400.43

u/l

0.04

346

Congenital malformations of aortic and mitral valves

112

2.80

6.49

1.4

283.35

401.49

u/l

0.58

107

Familial hypercholesterolemia

126

773

1.64

6.49

1.3

299.15

495.69

u/l

1.22

118

734

Benign neoplasm: Ascending colon

119

721

1.66

6.44

1.5

1.3

277.84

353.24

u/l

0.71

109

687

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

185

1242

1.49

6.38

1.3

352.87

395.97

u/l

0.38

175

1184

Obesity due to excess calories

235

1652

1.43

6.37

1.4

1.3

403.12

533.21

u/l

1.12

218

1581

Malignant neoplasm of rectum

329

1.99

6.34

1.3

1357.84

266.91

u/l

0.54

309

Bicuspidal aortic valve syndrome

108

2.81

6.34

1.4

273.63

411.55

u/l

0.69

103

Neurological diseases, wide definition

110

317

1.75

6.30

1.3

1.2

425.40

668.92

u/l

0.85

102

308

Superficial injury of head

158

1029

1.54

6.27

1.3

662.85

375.16

u/l

0.48

151

978

Alzheimer disease, including avohilmo

202

2015

0.69

6.21

1.3

428.97

430.23

u/l

0.00

186

1912

Progressive systemic sclerosis

13.19

6.16

1.4

1.1

146.80

173.84

u/l

—

Malignant neoplasm of prostate, including Hilmo

191

755

1.50

6.14

1.4

460.26

461.14

u/l

0.00

178

704

Any mental disorder

649

2616

1.24

6.12

1.3

619.71

434.51

u/l

1.09

611

2491

Cholelithiasis

523

2820

1.27

6.11

1.3

366.09

496.18

u/l

1.12

492

2671

Degeneration of macula and posterior pole

401

2371

1.31

6.10

1.3

335.48

441.00

u/l

1.02

384

2240

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

108

638

1.68

6.10

1.4

1.3

537.62

387.16

u/l

1.35

100

616

353

2398

1.33

6.09

1.4

1.3

347.25

431.48

u/l

0.67

335

2269

Other viral diseases, including avohilmo

160

1042

1.52

6.09

1.4

1.3

399.61

405.35

u/l

0.03

149

990

Use of other anti-dementia drugs

143

1760

0.65

6.08

1.3

334.36

446.06

u/l

0.99

130

1663

Use of memantine

143

1760

0.65

6.08

1.3

334.36

446.06

u/l

0.99

130

1663

Migraine, single triptan purchase ok & required. ICD-code if available is included

165

1665

0.67

6.02

1.3

479.91

436.34

u/l

0.23

159

1585

Triptan medication for migraine, single purchase ok

165

1665

0.67

6.02

1.3

479.91

436.34

u/l

0.23

159

1585

Malignant neoplasm of rectum, including Hilmo

406

1.86

6.02

1.3

1210.78

299.91

u/l

0.53

382

Retinal vascular disorders

109

660

1.66

5.95

1.3

299.49

398.72

u/l

0.67

103

617

Fracture of foot, except ankle

126

792

1.60

5.89

1.3

429.08

393.08

u/l

0.21

111

757

Schizophrenia or delusion, excluding more controls

144

922

1.55

5.87

1.3

562.26

368.15

u/l

2.66

136

881

Retinal vascular occlusion

107

648

1.66

5.85

1.3

301.31

341.57

u/l

0.34

102

608

Noninfective enteritis and colitis

260

1887

1.38

5.85

1.3

489.69

502.43

u/l

0.03

240

1794

Obesity

318

2242

1.34

5.83

1.4

1.3

404.26

507.60

u/l

1.13

296

2138

Actinic keratosis

336

2311

1.33

5.79

1.4

1.3

352.75

429.93

u/l

0.56

320

2186

Weight loss

441

1.81

5.77

1.3

1.4

729.04

345.98

u/l

0.57

422

Other neurological diseases

496

3050

1.26

5.77

1.4

1.3

324.46

492.21

u/l

3.14

462

2893

Dentofacial anomalies [including malocclusion]

161

1862

0.67

5.74

1.4

1.3

351.73

444.88

u/l

1.13

151

1781

Right hemicolectomy

280

2.02

5.73

1.2

1.4

265.78

313.14

u/l

0.42

271

Symptoms and signs involving the skin and subcutaneous tissue

428

3163

1.28

5.69

1.3

428.82

486.23

u/l

0.44

401

2999

Skin changes due to chronic exposure to nonionizing radiation

339

2330

1.32

5.68

1.4

1.3

352.72

428.97

u/l

0.56

323

2204

Delirium, not induced by alcohol and other psychoactive substances

122

769

1.59

5.64

1.2

1.3

588.88

356.73

u/l

0.48

111

726

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

294

1993

1.35

5.62

1.4

1.3

447.22

537.51

u/l

0.35

283

1891

Covid-19 suspected case

563

1.69

5.62

1.5

1.3

367.90

375.82

u/l

0.05

534

Sequelae of cerebrovascular disease

309

1979

1.34

5.61

1.3

414.26

479.60

u/l

0.35

291

1883

Statin medication

318

1334

1.34

5.59

1.3

298.48

603.80

u/l

4.21

298

1261

Use of disulfiram, acamprosate or naltrexone

235

2.10

5.58

1.4

446.45

438.33

u/l

0.04

225

Obesity and other hyperalimentation

318

2255

1.33

5.57

1.4

1.3

404.26

505.83

u/l

1.10

296

2151

Diabetic maculopathy

540

1.69

5.55

1.4

1.3

194.71

352.34

u/l

3.14

509

Other and unspecified drugs and medicaments

283

1.99

5.55

1.4

1.3

280.59

364.51

u/l

0.87

273

Adenocarcinoma and papilloma adenocarcinoma of rectum

325

1.92

5.52

1.3

353.62

306.71

u/l

0.18

305

Alcohol withdrawal state with delirium

277

2.01

5.52

1.3

1.4

2011.91

354.98

u/l

0.97

266

Other disorders of adrenal gland

136

2.45

5.38

1.3

278.64

371.34

u/l

0.36

131

Exclusions for E4_PCOS_CONSORTIUM

288

1333

1.35

5.34

1.3

501.36

402.71

u/l

0.47

271

1268

Diseases of the musculoskeletal system and connective tissue

269

984

1.37

5.33

1.4

1.3

360.77

604.20

u/l

2.08

254

941

Acute upper respiratory infections of multiple and unspecified sites

420

2404

1.28

5.31

1.3

418.16

508.41

u/l

0.86

397

2281

Cardiomyopathies, Secondary/extrinsic

6.92

5.31

1.2

1.5

197.08

392.17

u/l

1.06

Osteoporosis with pathological fracture (FG)

316

1.92

5.30

1.3

248.65

350.48

u/l

0.68

298

Gastro-oesophageal reflux disease

399

2632

1.28

5.30

1.4

1.3

615.32

480.21

u/l

0.38

374

2511

Other spirochaetal diseases

1423

0.60

5.28

1.3

269.99

412.31

u/l

2.84

1360

Thoracic aortic aneurysm

118

754

1.58

5.23

1.4

1.3

385.71

502.04

u/l

0.56

111

719

Other reaction to severe stress, and adjustment disorders

137

903

1.52

5.22

1.3

382.55

405.22

u/l

0.17

129

853

Spondyloarthritis

110

691

1.60

5.22

1.2

1.3

879.94

345.22

u/l

0.58

656

Poisoning by medicine

530

1.68

5.20

1.2

1.3

596.78

402.85

u/l

1.44

509

Lyme disease, including avohilmo

1415

0.61

5.17

1.3

269.99

411.07

u/l

2.79

1352

Lyme disease

1415

0.61

5.17

1.3

269.99

411.07

u/l

2.79

1352

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

347

1.85

5.16

1.2

1.4

708.70

418.67

u/l

1.72

333

Low back pain

447

2392

1.26

5.15

1.3

450.47

498.66

u/l

0.30

414

2272

Other spirochaetal diseases, including avohilmo

1437

0.61

5.14

1.3

265.80

428.16

u/l

3.23

1373

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

341

1.86

5.12

1.3

350.30

313.75

u/l

0.14

320

Spirochaetal infections, other/unspecified, including avohilmo

1423

0.61

5.11

1.3

268.14

412.48

u/l

2.94

1360

Noninfectious colitis NAS

473

1.72

5.11

1.4

553.95

339.75

u/l

0.29

451

Fracture of lower leg, including ankle

314

2355

1.31

5.11

1.3

696.04

461.35

u/l

0.53

296

2247

Paracetamol or NSAID medication

100

301

1.68

5.10

1.3

417.97

454.84

u/l

0.09

289

Disorder of lipoprotein metabolism, unspecified

104

649

1.61

5.10

1.3

410.22

358.53

u/l

0.29

616

Chronic gastritis

198

1412

1.41

5.08

1.4

1.3

550.99

422.67

u/l

0.22

186

1354

Obesity, other/unspecified

153

1041

1.47

5.04

1.4

1.3

454.86

394.63

u/l

0.45

144

993

Alzheimer’s disease, strict definition

134

1605

0.67

5.00

1.3

418.23

391.57

u/l

0.08

121

1523

Any prescribed medicine buy

+∞

4.98

1.5

0.0

240.67

—

u/l

—

Methotrexate

447

1.73

4.97

1.4

1.3

557.32

360.22

u/l

1.14

422

Nonhereditary hypogammaglobulinemia

5.56

4.95

2.1

1.2

247.69

697.10

u/l

0.56

Disorders of parathyroid gland

142

945

1.49

4.94

1.3

236.02

348.31

u/l

2.30

132

893

Dizziness and giddiness

460

2872

1.25

4.88

1.3

354.79

479.95

u/l

2.05

429

2737

Allergic bronchopulmonary aspergillosis (ABPA)

11.95

4.84

1.4

499.00

582.29

u/l

—

Familial hypercholesterolemia, with ischemic heart disease

506

1.67

4.78

1.3

327.48

368.76

u/l

0.27

484

Malignant neoplasm of cervix uteri, including Hilmo

5.25

4.78

1.1

1.2

181.23

602.44

u/l

0.54

Alzheimer’s disease (Late onset)

126

1541

0.67

4.76

1.3

404.29

395.25

u/l

0.03

114

1460

Sequelae of injuries, of poisoning and of other consequences of external causes

130

868

1.50

4.74

1.3

492.93

366.20

u/l

0.59

120

828

Insomnia

299

2699

0.77

4.74

1.3

489.07

488.41

u/l

0.00

283

2561

Other viral diseases, not elsewhere classified

543

1.64

4.72

1.3

496.37

366.48

u/l

0.69

523

Use of donepezil

1419

0.63

4.68

1.3

370.95

378.03

u/l

0.04

1341

DVT of lower extremities

137

928

1.48

4.67

1.3

558.46

415.51

u/l

0.42

126

871

Dementia in Alzheimer disease

1174

0.62

4.67

1.3

282.14

358.52

u/l

0.79

1116

Urinary track infection

210

755

1.40

4.64

1.3

444.17

396.94

u/l

0.19

199

718

Schizophrenia, schizotypal and delusional disorders

145

997

1.46

4.57

1.2

1.3

560.54

370.11

u/l

2.62

137

945

Schizophrenia or delusion

144

989

1.46

4.57

1.2

1.3

562.26

373.74

u/l

2.55

136

938

Alzheimer disease

186

1834

0.72

4.57

1.3

424.66

433.03

u/l

0.03

168

1734

Diseases of pulp and periapical tissues, including avohilmo

614

2634

1.21

4.49

1.3

390.74

464.41

u/l

0.67

586

2488

Diaphragmatic hernia

244

1838

1.33

4.49

1.4

1.3

495.11

445.01

u/l

0.19

234

1748

Abnormal weight loss

409

1.72

4.47

1.3

1.4

350.14

351.00

u/l

0.00

391

Acute and transient psychotic disorders

299

1.85

4.46

1.3

1.4

577.82

362.07

u/l

1.24

288

Abdominal aortic aneurysm (AAA)

102

652

1.56

4.43

1.3

365.84

467.56

u/l

0.46

620

Injuries to the elbow and forearm

377

2576

1.26

4.37

1.2

1.3

601.54

477.07

u/l

0.36

353

2450

Other and unspecified immunodeficiencies with predominantly antibody defects

5.10

4.34

2.1

1.3

470.75

705.55

u/l

0.22

Benign neoplasm: Colon, unspecified

193

1412

1.37

4.33

1.4

1.3

369.85

473.14

u/l

0.76

178

1341

Dental operations

428

1768

1.25

4.31

1.4

1.3

320.93

451.20

u/l

1.65

407

1671

Caries of enamel

331

2740

0.79

4.30

1.3

522.86

506.96

u/l

0.07

319

2596

Other follicular disorders

185

2.07

4.24

1.4

336.33

408.22

u/l

0.34

173

Idiopathic pulmonary fibrosis

462

1.66

4.23

1.5

1.3

491.43

330.69

u/l

1.34

437

Unspecified jaundice

206

2.01

4.22

1.1

1.3

642.71

307.43

u/l

0.36

196

Sleep disorders

323

2813

0.79

4.21

1.3

476.57

506.59

u/l

0.12

306

2670

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

501

3216

1.21

4.19

1.3

383.70

496.49

u/l

1.72

472

3044

Diseases of the eye and adnexa

366

1451

1.27

4.17

1.4

1.3

357.64

503.59

u/l

3.01

349

1374

Conductive and sensorineural hearing loss

514

2819

1.21

4.14

1.3

373.96

504.47

u/l

1.63

486

2671

Benign neoplasm: Sigmoid colon

141

986

1.44

4.13

1.5

1.3

298.37

358.95

u/l

0.95

134

933

Other viral diseases, not elsewhere classified, including avohilmo

111

736

1.50

4.11

1.3

455.33

390.99

u/l

0.36

104

706

Assault

293

1.82

4.10

1.2

1.3

1432.74

398.97

u/l

1.11

281

Other and unspecified diseases of blood and blood-forming organs

104

2.44

4.08

1.2

1.3

248.60

403.06

u/l

0.72

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

10.67

4.08

1.9

1.3

331.57

286.29

u/l

—

Restrictive cardiomyopathy

5.93

4.06

1.3

135.90

216.48

u/l

—

Leisure time condition

107

711

1.51

4.06

1.4

798.11

330.69

u/l

0.53

101

677

Mental and behavioural disorders due to cannabinoids

5.03

4.00

1.3

1.1

3004.18

819.50

u/l

0.46

Degeneration of the brain due to alcohol

2.47

4.00

1.2

1.4

361.29

318.48

u/l

0.18

Zoster [herpes zoster], including avohilmo

331

2543

1.26

4.00

1.4

1.3

305.41

510.22

u/l

4.46

314

2417

Suicide or other Intentional self-harm

105

698

1.51

3.98

1.4

1.3

549.26

384.36

u/l

1.51

666

Missing teeth due to accident, extraction or parodontitis

403

2927

1.23

3.98

1.3

460.51

477.30

u/l

0.09

382

2776

Sulfonylureas

288

1789

1.28

3.96

1.4

1.3

235.80

495.53

u/l

4.85

269

1706

Transient ischemic attack

382

2461

1.24

3.92

1.4

1.3

304.30

487.44

u/l

2.81

360

2345

Sleep apnoea

551

2904

1.20

3.90

1.4

1.3

495.50

500.09

u/l

0.01

519

2759

Other disorders of ear

545

2944

1.20

3.88

1.3

374.53

505.77

u/l

2.07

517

2785

Dental pulpitis, including avohilmo

291

2361

0.79

3.86

1.3

446.84

514.97

u/l

0.66

274

2242

Psychiatric diseases

568

2383

1.20

3.81

1.3

481.33

444.56

u/l

0.20

532

2268

Dorsalgia

549

2432

1.20

3.79

1.3

395.60

498.03

u/l

1.08

518

2310

Degenerative diseases of the nervous system

213

2008

0.76

3.78

1.2

1.3

498.84

432.25

u/l

0.23

197

1903

Degeneration of nervous system due to alcohol

102

2.39

3.77

1.2

1.4

361.29

319.45

u/l

0.18

Diseases of the myoneural junction and muscle

579

1.55

3.77

1.3

1.4

906.70

329.14

u/l

0.55

550

Exclusions for E4_PCOS_BROAD

547

1.56

3.75

1.2

1.4

415.87

364.68

u/l

0.34

525

Other systemic involvement of connective tissue (FG)

153

1085

1.39

3.74

1.3

501.01

435.20

u/l

0.19

142

1028

Other condition

485

1.59

3.74

1.3

1.4

409.46

361.85

u/l

0.32

465

Dermatitis and eczema

636

3200

1.18

3.71

1.4

1.3

374.60

502.95

u/l

2.16

601

3027

Dementia, including avohilmo

269

2328

0.79

3.69

1.2

1.3

390.39

422.41

u/l

0.17

251

2211

Sensorineural hearing loss

499

2780

1.20

3.62

1.3

377.05

505.99

u/l

1.55

472

2634

Gonarthrosis, primary, with knee surgery

281

2751

0.79

3.62

1.3

356.77

500.08

u/l

2.12

268

2605

Benign thyroid growths and nodules

184

1280

1.34

3.58

1.4

1.3

380.53

382.60

u/l

0.01

176

1214

Dementia

252

2195

0.78

3.58

1.2

1.3

400.09

416.44

u/l

0.08

235

2085

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

108

740

1.46

3.57

1.4

1.3

537.62

387.84

u/l

1.36

100

703

Hyperparathyroidism

120

830

1.44

3.57

1.3

205.31

349.49

u/l

3.46

111

781

Collagenous colitis

337

1.70

3.57

1.2

1.4

367.85

335.27

u/l

0.19

325

Colectomy operation

120

841

1.43

3.54

1.2

1.4

306.53

345.90

u/l

0.43

112

800

Benign neoplasm: Connective and other soft tissue of thorax

6.39

3.54

1.0

1.5

396.75

241.12

u/l

—

Selective deficiency of immunoglobulin G [IgG] subclasses

6.31

3.53

1.6

1.3

477.00

319.52

u/l

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

10.34

3.53

1.0

502.33

194.45

u/l

—

Injuries to the knee and lower leg

668

3094

1.17

3.50

1.3

540.11

471.69

u/l

0.27

624

2938

Unknown and unspecified causes of morbidity

221

1.87

3.49

1.4

240.87

366.54

u/l

1.22

215

Behavioural syndromes associated with physiological disturbances and physical factors

350

2900

0.81

3.48

1.3

467.95

507.16

u/l

0.18

332

2747

Infections with a predominantly sexual mode of transmission

623

1.49

3.41

1.3

386.70

415.14

u/l

0.19

587

Contact with and exposure to communicable diseases

558

1.52

3.39

1.4

1.3

303.56

440.64

u/l

2.22

532

Other necrotizing vasculopathies

312

1.71

3.39

1.4

392.28

316.98

u/l

0.48

302

266

1814

1.26

3.35

1.3

359.23

435.20

u/l

0.41

252

1717

Intestinal malabsorption

141

2.07

3.32

1.5

1.3

377.96

422.01

u/l

0.16

136

Other nonthrombocytopenic purpura

3.72

3.32

1.8

1.2

495.50

582.89

u/l

0.10

Coeliac disease

375

1.63

3.31

1.3

1.4

229.76

363.98

u/l

2.07

362

Anorexia

3.69

3.30

1.4

1.2

2562.42

612.40

u/l

0.44

Use of antiglaucoma preparations and miotics

400

1.61

3.27

1.3

1.4

677.57

328.73

u/l

0.42

379

Alcohol abuse, main dg, excluding more controls

510

1.53

3.27

1.2

1.4

544.38

376.29

u/l

0.73

492

Osteonecrosis

241

1.80

3.27

1.3

1.4

713.12

352.03

u/l

0.72

234

Inflammatory diseases of the central nervous system

263

1.76

3.26

1.2

1.3

244.70

361.84

u/l

1.15

254

Arthropathies

464

1960

1.20

3.26

1.4

1.3

427.45

537.99

u/l

0.55

433

1868

Retinal detachments and breaks

245

1939

1.27

3.23

1.3

648.49

489.48

u/l

0.32

238

1839

Fracture of shoulder and upper arm

216

1680

1.29

3.23

1.3

557.05

397.61

u/l

0.33

206

1596

Dermatophytosis

625

1.48

3.23

1.4

362.34

355.12

u/l

0.04

600

Injuries to unspecified part of trunk, limb or body region

378

1.62

3.22

1.4

265.72

352.65

u/l

0.87

362

Other diseases of urinary system

576

2762

1.17

3.20

1.4

1.3

370.57

511.33

u/l

2.08

541

2623

Complications of internal orthopaedic prosthetic devices, implants and grafts

155

1157

1.34

3.17

1.4

1.3

521.34

433.11

u/l

0.18

145

1098

Gingivitis and periodontal diseases

595

2634

1.17

3.14

1.3

434.18

456.12

u/l

0.13

567

2486

Other and unspecified myopathies

413

1.58

3.12

1.4

1.3

1144.68

345.99

u/l

0.54

389

Drug-induced polyneuropathy

3.76

3.11

1.3

665.18

251.86

u/l

0.69

Cardiomyopathy due to drugs and other external agents

8.02

3.11

1.3

221.50

293.79

u/l

—

Hernia of abdominal wall

280

2263

1.24

3.09

1.3

375.16

527.20

u/l

1.85

263

2152

Endometroid carcinoma of ovary, including Hilmo

5.10

3.07

1.4

1.1

270.50

260.06

u/l

—

Ulcer of oesophagus

330

1.65

3.05

1.3

328.31

358.97

u/l

0.15

317

Drug-induced interstitial lung disorders, unspecified

10.61

3.02

1.6

1.4

259.00

135.32

u/l

—

Injury of unspecified body region

285

1.69

3.01

1.5

1.3

284.09

354.17

u/l

0.47

274

Acute alcohol intoxication, ICD10

110

784

1.41

3.01

1.3

1.4

673.34

388.68

u/l

0.85

101

752

Umbilical hernia

161

1220

1.32

2.99

1.2

1.3

429.12

542.51

u/l

0.63

151

1160

Other symptoms and signs involving cognitive functions and awareness

332

2426

1.22

2.99

1.3

414.44

473.56

u/l

0.31

305

2319

Spondylopathies

474

2374

1.18

2.98

1.3

549.08

485.23

u/l

0.23

441

2256

Diseases of pulp and periapical tissues and dental caries

427

1835

1.19

2.97

1.4

1.3

326.82

411.38

u/l

1.18

406

1730

189

1368

1.29

2.95

1.3

383.13

384.55

u/l

0.00

176

1291

Other disorders of veins

222

1729

1.27

2.95

1.3

577.54

451.99

u/l

0.44

212

1641

Benign neoplasm of other and ill-defined parts of digestive system

113

815

1.39

2.91

1.3

297.54

358.32

u/l

0.55

103

773

Hypothyroidism, strict autoimmune

385

2110

1.20

2.90

1.3

458.34

513.38

u/l

0.17

364

2009

Caries of dentine, including avohilmo

490

2129

1.18

2.90

1.4

1.3

341.45

426.27

u/l

1.33

460

2013

Symptoms and signs involving the nervous and musculoskeletal systems

338

2804

1.21

2.90

1.3

513.38

478.69

u/l

0.09

322

2661

Injury of nerves and spinal cord at thorax level

6.83

2.89

1.0

1.1

736.50

280.33

u/l

—

Inguinal hernia

378

2097

1.20

2.88

1.3

523.64

497.62

u/l

0.08

359

1986

Conotruncal defects

5.44

2.87

1.3

396.37

294.43

u/l

—

Fracture of forearm

281

2055

1.23

2.87

1.2

1.3

531.72

430.70

u/l

0.36

263

1958

Malignant neoplasm of cervix uteri

5.43

2.87

1.0

1.1

211.43

1036.46

u/l

—

Dental caries, including avohilmo

472

2050

1.18

2.87

1.4

1.3

338.79

430.36

u/l

1.39

445

1935

Triptan medication for migraine, min. 3 purchases

1011

0.71

2.85

1.4

1.3

430.61

446.80

u/l

0.08

960

Phobic anxiety disorders

192

1.82

2.85

1.3

1205.12

410.93

u/l

0.58

182

Alzheimer’s disease (Late onset), excluding more controls

725

0.68

2.83

1.2

1.3

467.73

424.41

u/l

0.08

698

Other diseases of anus and rectum

195

1524

1.28

2.82

1.3

519.18

473.94

u/l

0.10

183

1454

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

2.78

2.82

1.2

1.4

778.31

537.77

u/l

0.27

Other diseases of liver

677

1.42

2.82

1.4

1.3

602.50

372.49

u/l

0.43

646

Procreative management

113

672

1.39

2.80

1.3

323.57

418.31

u/l

1.38

107

638

Palmar fascial fibromatosis [Dupuytren]

124

916

1.36

2.78

1.4

1.3

285.16

531.51

u/l

2.03

117

867

Tonsillectomy and adenotomy

921

0.71

2.77

1.3

508.99

449.06

u/l

0.34

875

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

588

1.45

2.76

1.3

1.4

238.46

349.94

u/l

2.10

560

Erectile dysfunction, exclusion

6.21

2.72

2.0

1.4

187.33

283.40

u/l

—

Congenital malformations of trachea and bronchus

3.52

2.71

1.5

1.3

210.20

304.29

u/l

—

Unspecified lump in breast

412

1.53

2.70

1.3

273.98

368.16

u/l

0.83

391

Psoriasis vulgaris

104

750

1.39

2.70

1.4

1.3

600.20

382.28

u/l

0.40

718

Benign neoplasm: Adrenal gland

319

1.61

2.66

1.4

291.10

352.94

u/l

0.54

305

Disorders of the thyroid gland

529

2967

1.16

2.65

1.3

424.36

490.22

u/l

0.30

499

2805

Periapical abscess

233

1887

1.24

2.59

1.3

485.97

529.09

u/l

0.21

217

1792

Other congenital malformations of respiratory system

7.58

2.59

1.4

1.1

319.00

229.57

u/l

—

Other dorsopathies, not elsewhere classified

541

2433

1.16

2.58

1.3

389.75

497.86

u/l

1.19

507

2311

Serous carcinoma of ovary

5.56

2.56

1.0

1.3

435.00

113.73

u/l

—

Psoriasis

152

1174

1.30

2.53

1.3

538.65

383.13

u/l

0.41

138

1118

Other and unspecified medical devices associated with adverse incidents

4.50

2.50

1.1

392.29

258.83

u/l

—

Benign neoplasm: Ill-defined sites within the digestive system

4.48

2.49

1.0

1.1

387.86

329.02

u/l

—

Ventricular septal defect, a heart condition

3.48

2.47

1.6

1.2

206.56

738.36

u/l

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

279

2233

1.21

2.44

1.4

1.3

433.45

530.49

u/l

0.68

261

2133

Disorders of pituitary gland, other and/or unspecified

5.11

2.42

1.2

1.3

268.50

252.67

u/l

—

Shoulder lesions

439

2260

1.16

2.41

1.3

400.14

490.73

u/l

0.79

416

2142

Fibroblastic disorders

158

1237

1.28

2.39

1.4

1.3

314.07

548.07

u/l

2.20

148

1175

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

699

1.38

2.39

1.3

1.4

243.15

358.52

u/l

2.34

666

Diabetic neuropathy

646

1.39

2.39

1.3

220.66

355.21

u/l

2.22

608

Mental disorders, not otherwise specified

160

1.82

2.39

1.2

1.4

386.83

379.68

u/l

0.03

152

Viral warts

266

1.62

2.37

1.3

1.4

602.85

347.09

u/l

0.39

257

Disorders of plasma-protein metabolism, not elsewhere classified

4.20

2.37

1.7

1.5

283.29

838.22

u/l

—

Abnormal serum enzyme levels

230

1816

1.23

2.35

1.3

1.4

380.42

544.42

u/l

1.28

218

1724

Epilepsy

178

1412

1.26

2.35

1.2

1.3

411.06

524.54

u/l

0.81

171

1352

Acute sinusitis

222

1643

1.23

2.35

1.4

1.3

544.53

478.46

u/l

0.21

205

1562

Benign neoplasm of other and unspecified endocrine glands

518

1.43

2.33

1.4

283.84

338.97

u/l

0.61

499

Other systemic involvement of connective tissue

156

1224

1.28

2.33

1.3

496.89

382.45

u/l

0.40

145

1161

Mycoses, including avohilmo

487

3227

1.15

2.33

1.3

496.63

488.52

u/l

0.02

460

3053

Any dementia

247

2065

0.82

2.32

1.2

1.3

418.31

427.64

u/l

0.04

230

1959

Diseases of oral cavity, salivary glands and jaws

385

1690

1.18

2.32

1.4

1.3

283.11

442.58

u/l

3.64

362

1594

Other disorders of urethra and urinary system

409

2445

1.16

2.31

1.3

405.44

499.36

u/l

0.80

375

2324

Unspecified mental disorder

169

1341

1.26

2.29

1.2

1.3

534.65

386.49

u/l

2.33

159

1278

Alcohol abuse, main dg

555

1.41

2.25

1.2

1.4

544.38

394.38

u/l

0.62

529

Disorders of continuity of bone

278

1.59

2.25

1.4

376.51

390.16

u/l

0.05

268

Injuries to the shoulder and upper arm

486

3275

1.15

2.23

1.3

538.97

474.55

u/l

0.24

460

3097

Superficial injury of hip and thigh

701

1.36

2.21

1.5

1.3

393.84

386.59

u/l

0.03

658

Hepatomegaly and splenomegaly, not elsewhere classified

3.38

2.19

1.0

1.5

172.50

690.74

u/l

—

Henoch-Schönlein purpura nephritis (HSPN)

4.42

2.17

1.3

1.4

118.17

239.04

u/l

—

Presence of other devices

173

1366

1.25

2.16

1.4

1.3

272.32

506.02

u/l

3.32

163

1298

Cystic kidney disease

101

2.00

2.16

1.8

1.3

239.62

404.39

u/l

0.73

Neurological diseases

428

1858

1.16

2.15

1.4

1.3

363.48

522.83

u/l

2.74

399

1776

Any dementia, excluding more controls

220

1829

0.82

2.13

1.2

1.3

414.07

413.94

u/l

0.00

206

1743

Disorders of eyelid, lacrimal system and orbit

497

3199

1.14

2.11

1.3

334.96

497.80

u/l

3.04

471

3027

Other abnormal uterine and vaginal bleeding

100

535

1.35

2.11

1.3

1.2

209.49

386.43

u/l

3.35

512

Injuries to the ankle and foot

315

2289

1.18

2.10

1.3

508.29

512.41

u/l

0.01

287

2184

Migraine

113

1145

0.77

2.10

1.5

1.3

362.91

443.64

u/l

1.06

105

1099

Intestinal helminthiases, other/unspecified, including avohilmo

5.19

2.09

1.8

1.3

136.00

362.26

u/l

—

Coxarthrosis [arthrosis of hip](FG)

348

2051

1.17

2.09

1.4

1.3

333.88

533.48

u/l

2.29

330

1948

Diseases of external ear

200

1638

1.22

2.08

1.3

707.24

467.66

u/l

0.44

183

1554

Melanoma in situ

206

1.66

2.08

1.3

466.18

390.07

u/l

0.23

198

Lower back pain or/and sciatica

586

3232

1.13

2.07

1.3

437.13

490.07

u/l

0.44

547

3063

Dorsopathies

545

2434

1.13

2.07

1.3

375.15

497.73

u/l

1.94

507

2312

Other infiltrative disorders of skin and subcutaneous tissue

4.10

2.05

1.7

1.1

347.33

865.55

u/l

—

Malignant neoplasm of vulva

4.05

2.04

1.0

1.3

736.83

169.53

u/l

—

Disease of hard tissues of teeth, NOS

247

1545

0.84

2.01

1.4

1.3

339.09

453.77

u/l

1.57

233

1459

Nonorganic sleeping disorders, excluding more controls

551

1.38

2.00

1.4

1.3

400.33

363.54

u/l

0.25

527

Functional dyspepsia

129

1012

1.28

1.98

1.3

347.57

412.44

u/l

0.63

117

976

Burns and corrosions of multiple body regions

3.38

1.97

1.0

1.1

418.57

357.29

u/l

—

Cholecystectomy

407

3017

1.15

1.96

1.3

362.04

485.54

u/l

1.27

379

2868

Secondary systemic amyloidosis

4.70

1.96

1.0

1.4

270.80

209.61

u/l

—

Myalgia

107

821

1.31

1.95

1.3

355.77

434.59

u/l

0.55

783

Other hereditary haemolytic anaemias

4.62

1.95

1.2

1.3

215.20

440.33

u/l

—

Papulosquamous disorders

207

1715

1.21

1.94

1.4

1.3

476.30

453.66

u/l

0.06

191

1637

Viral and other specified intestinal infections, including avohilmo

681

1.33

1.94

1.3

295.62

388.96

u/l

1.56

646

Use of glatiramer acetate

3.77

1.94

1.2

1.3

658.65

975.69

u/l

—

Postmenopausal osteoporosis with pathological fracture

242

1.58

1.93

1.2

1.3

196.24

249.08

u/l

0.68

230

Fall on and from stairs and steps

141

1123

1.26

1.92

1.4

1.3

1222.48

368.52

u/l

0.86

132

1065

Disorders of skin appendages

212

1755

1.20

1.90

1.4

1.3

377.65

480.48

u/l

0.91

204

1666

Infections with a predominantly sexual mode of transmission, including avohilmo

106

745

1.30

1.89

1.3

375.32

423.47

u/l

0.42

100

705

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

3.21

1.88

1.7

1.1

332.71

743.15

u/l

—

Gluteal tendinitis

139

0.36

1.88

1.0

1.4

338.80

339.34

u/l

—

134

Primary gonarthrosis, bilateral

265

2603

0.85

1.87

1.4

1.3

359.09

504.96

u/l

2.10

252

2468

Pneumoconiosis due to asbestos and other mineral fibres

129

1.80

1.87

1.4

415.85

308.37

u/l

0.44

123

Kela-code for severe mental illness

153

1237

1.24

1.84

1.2

1.3

560.34

373.87

u/l

3.16

144

1179

Oral lichen planus, including avohilmo , including avohilmo

223

0.45

1.84

1.6

1.4

332.45

340.43

u/l

—

216

Sleep apnoea, including avohilmo

544

2932

1.12

1.83

1.4

1.3

495.43

497.63

u/l

0.01

512

2783

Acute upper respiratory infections

584

3134

1.12

1.81

1.4

1.3

398.24

488.41

u/l

1.22

551

2965

Malignant neoplasm of vulva, including Hilmo

3.07

1.80

1.0

1.2

853.00

156.27

u/l

—

Primary adrenocortical insufficiency

2.79

1.80

1.6

1.2

142.00

593.60

u/l

—

Cystic kidney disease, including avohilmo

116

1.82

1.79

1.8

1.4

230.97

385.66

u/l

0.78

111

Carcinoma in situ of skin of lower limb, including hip

109

1.86

1.78

1.3

171.90

258.07

u/l

1.34

104

Follow-up examination after treatment for conditions other than malignant neoplasms

213

1184

1.20

1.78

1.3

786.72

497.96

u/l

0.56

199

1123

Polycystic ovarian syndrome, consortium definition

238

1149

1.19

1.77

1.4

1.2

307.13

408.16

u/l

1.95

221

1097

Herpesviral [herpes simplex] infections, including avohilmo

732

1.30

1.72

1.3

372.63

359.59

u/l

0.09

689

Benign neoplasm: Skin of other and unspecified parts of face

448

1.39

1.72

1.3

1.4

286.07

331.78

u/l

0.41

429

Conjunctivitis (acute, non atopic), including avohilmo

440

2994

0.89

1.72

1.3

429.18

496.21

u/l

0.71

404

2844

Coarctation of the aorta

3.88

1.72

2.2

1.2

370.40

1105.85

u/l

—

Allergic colitis

3.85

1.71

1.0

1.3

3892.20

475.89

u/l

—

Exposure to other specified factors

390

2951

1.13

1.68

1.3

686.76

470.58

u/l

0.78

375

2793

Anxiety (asthma-related co-morbidities)

215

1376

1.19

1.68

1.3

641.27

404.50

u/l

1.10

203

1314

Other and unspecified pemphigoid

2.62

1.67

1.9

1.5

288.13

331.75

u/l

—

Otitis externa

111

877

1.27

1.67

1.3

572.78

361.14

u/l

0.79

102

833

Agoraphobia

2.59

1.66

1.5

1.2

479.63

631.38

u/l

—

Neuromuscular dysfunction of bladder

401

1.40

1.65

1.2

1.4

317.02

359.60

u/l

0.30

383

Other/unspecified dorsalgia

195

1616

1.19

1.65

1.3

370.47

507.78

u/l

1.34

184

1546

Benign neoplasm: Rectum, anus and anal canal

134

1085

1.24

1.64

1.4

1.3

791.50

355.08

u/l

0.44

127

1025

Acute alcohol intoxication

145

1184

1.23

1.63

1.3

612.42

449.73

u/l

0.53

131

1131

Other and unspecified disorders of vitreous body

174

2037

0.83

1.62

1.3

397.72

475.64

u/l

0.63

165

1944

Other anxiety disorders

152

1059

1.22

1.62

1.3

487.91

403.35

u/l

0.69

142

1001

Implicit parasitic Sepsis

3.64

1.62

1.8

1.4

271.80

245.91

u/l

—

Other and unspecified nonscarring hair loss

3.61

1.62

1.6

1.2

140.60

1069.05

u/l

—

Superficial injury of lower leg

115

917

1.26

1.61

1.3

320.62

356.92

u/l

0.37

109

874

Postprocedural musculoskeletal disorders, not elsewhere classified

303

1.46

1.61

1.2

1.4

639.64

334.10

u/l

0.42

294

Benign neoplasm: Stomach

404

1.39

1.59

1.3

1.4

271.84

327.42

u/l

0.36

393

Glaucoma secondary to eye inflammation

2.73

1.59

1.3

1.5

313.14

315.77

u/l

—

Myocardial infarction, with ST-elevation

135

1099

1.23

1.58

1.4

1.3

439.86

390.29

u/l

0.16

125

1037

Other hearing loss

212

1744

1.18

1.58

1.3

386.56

468.74

u/l

0.44

202

1654

Myocardial infarction, unclassifiable

182

1362

1.20

1.57

1.3

268.81

391.21

u/l

1.99

167

1286

Benign neoplasm: Caecum

542

1.33

1.57

1.4

236.96

335.57

u/l

1.78

515

Deep bite

195

0.49

1.56

1.2

1.4

443.82

421.23

u/l

0.06

186

Other abnormal immunological findings in serum

2.29

1.56

1.1

1.5

600.20

508.78

u/l

—

Soft tissue disorders related to use, overuse and pressure

150

1238

1.21

1.54

1.4

1.3

645.83

487.56

u/l

0.20

140

1184

!Aliquae complicationes praecoces traumatis

153

1.64

1.53

1.5

1.3

1215.31

374.88

u/l

0.40

147

Early complications of trauma

153

1.64

1.53

1.5

1.3

1215.31

374.88

u/l

0.40

147

Sequelae of injuries of upper limb

298

1.45

1.53

1.4

392.03

336.65

u/l

0.15

285

Other disorders of bone

589

1.31

1.51

1.4

1.3

343.00

401.88

u/l

0.53

561

Metatarsalgia

291

1.45

1.50

1.4

1.3

310.27

335.68

u/l

0.15

280

Ventral hernia

138

1136

1.22

1.47

1.3

316.30

449.54

u/l

1.17

130

1075

Postprocedural disorders of digestive system, not elsewhere classified

124

1.70

1.47

1.3

1.4

347.76

388.88

u/l

0.13

119

Alzheimer disease, excluding more controls

798

0.79

1.47

1.2

1.3

346.01

418.79

u/l

0.44

768

Other specified/unspecified hearing loss

428

1.36

1.46

1.3

538.15

326.85

u/l

0.38

407

Nerve, nerve root and plexus disorders

587

3203

1.10

1.45

1.4

1.3

342.51

504.84

u/l

3.79

546

3039

Maze procedure for atrial fibrillation

3.19

1.45

2.6

1.3

155.32

181.63

u/l

—

3.18

1.45

1.4

1.3

442.20

280.08

u/l

—

Implicit parasitic Sepsis, including avohilmo

3.17

1.44

1.8

1.4

271.80

282.29

u/l

—

Microscopic polyangiitis

2.77

1.44

1.5

1.2

367.17

333.74

u/l

—

Non-selective monoamine reuptake inhibitors

202

1654

1.17

1.44

1.3

732.96

456.59

u/l

0.55

187

1576

Glucagon-like peptide-1 (GLP-1) analogues

141

1166

1.21

1.44

1.3

373.90

616.38

u/l

1.94

133

1116

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

141

1166

1.21

1.44

1.3

373.90

616.38

u/l

1.94

133

1116

Otorrhagia

2.76

1.44

1.3

128.00

700.79

u/l

—

Systemic sclerosis,strict definition

2.76

1.44

1.2

1.1

214.83

763.60

u/l

—

Diseases of salivary glands

153

1276

1.20

1.43

1.3

433.35

399.52

u/l

0.25

141

1215

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

319

1.41

1.43

1.2

1.3

415.19

407.07

u/l

0.03

303

Appendectomy

273

2270

1.15

1.42

1.4

1.3

386.88

529.30

u/l

1.84

261

2155

Horner syndrome

2.43

1.39

1.6

1.3

438.00

688.42

u/l

—

Coxarthrosis

315

1791

1.14

1.39

1.4

1.3

351.62

522.54

u/l

1.60

298

1708

Hallux valgus (acquired)

119

1039

0.82

1.38

1.3

383.75

414.42

u/l

0.23

114

995

Melanoma in situ of upper limb, including shoulder

2.64

1.37

1.7

1.3

358.33

338.27

u/l

—

Autoimmune hepatitis

2.64

1.37

1.3

1.1

178.50

693.24

u/l

—

Hydrocele

723

1.26

1.37

1.3

919.19

549.51

u/l

0.34

696

ILD and respiratory illness in diseases classified elsewhere

2.99

1.36

1.4

1.3

442.20

284.84

u/l

—

Faecal incontinence

331

1.39

1.36

1.4

1.3

394.75

395.88

u/l

0.00

317

Abrasion of teeth

111

1356

0.82

1.33

1.3

354.59

408.39

u/l

0.62

106

1294

Pemphigoid

136

1.63

1.33

1.5

1.3

367.38

280.91

u/l

0.30

130

Chronic laryngitis and laryngotracheitis

603

1.28

1.31

1.4

1.3

377.96

350.66

u/l

0.20

574

Psoriatic and enteropathic arthropathies

377

1.36

1.30

1.4

1.3

519.84

381.72

u/l

0.83

359

Benign neoplasm: Rectosigmoid junction

177

1.53

1.29

1.3

1.4

276.77

337.16

u/l

0.38

171

Unspecified contracted kidney

2.82

1.29

1.8

1.3

190.20

247.79

u/l

—

Other forms of systemic lupus erythematosus

2.80

1.29

1.0

1.3

233.80

280.41

u/l

—

Colitis, primary sclerosing, strict definition

2.80

1.29

1.2

288.40

833.11

u/l

—

Combinations of oral blood glucose lowering drugs

167

1421

1.18

1.28

1.3

284.17

523.79

u/l

3.14

157

1354

Atopic dermatitis

159

1491

0.85

1.28

1.4

1.3

373.50

427.78

u/l

0.60

153

1418

Disorders of conjunctiva

317

2753

0.89

1.26

1.4

1.3

460.66

509.36

u/l

0.23

296

2614

Cerebral cysts

170

1.53

1.26

1.2

1.4

345.00

382.52

u/l

0.11

164

Other enthesopathy of foot (+metatarsalgia)

311

1.39

1.25

1.4

1.3

304.18

334.25

u/l

0.19

299

Colitis, primary sclerosing

2.41

1.24

1.2

1.1

290.50

820.56

u/l

—

Other and unspecified glaucoma

346

1.36

1.24

1.3

1.4

938.64

298.11

u/l

0.60

333

Spinal stenosis

334

2198

1.12

1.24

1.3

441.39

484.36

u/l

0.23

316

2094

Conjunctivitis

261

2380

0.88

1.24

1.4

1.3

496.81

487.79

u/l

0.03

245

2262

Labour and delivery complicated by fetal stress [distress]

141

0.55

1.22

1.1

1.3

248.08

522.17

u/l

2.20

133

Thiamine deficiency

2.67

1.22

1.4

103.40

192.88

u/l

—

Benign neoplasm: Rectum

115

952

1.21

1.22

1.5

1.3

873.07

356.39

u/l

0.44

108

902

Episodal and paroxysmal disorders

566

2629

1.09

1.21

1.3

336.95

511.36

u/l

4.42

524

2497

Hyperplasia of prostate

268

1330

1.14

1.20

1.4

1.3

370.18

588.29

u/l

2.05

252

1270

Benign neoplasm: Short bones of lower limb

2.33

1.19

1.3

675.00

705.93

u/l

—

Benign neoplasm: Oesophagus

2.12

1.19

1.3

1.4

324.13

554.64

u/l

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

2.32

1.19

1.3

1.2

390.83

664.87

u/l

—

Benign paroxysmal vertigo

117

1399

0.83

1.17

1.4

1.3

334.65

357.66

u/l

0.18

108

1326

Mental retardation, excluding more controls

1.87

1.16

1.3

1.4

558.25

457.70

u/l

0.18

Alcoholic cardiomyopathy

2.54

1.16

1.2

1.3

187.20

312.00

u/l

—

473

1.29

1.15

1.5

1.3

1079.25

334.16

u/l

0.44

446

Unspecified threat to breathing

2.52

1.15

2.0

1.2

284.80

730.12

u/l

—

Hypothyroidism, other/unspecified

459

2750

1.10

1.15

1.3

429.86

490.71

u/l

0.23

431

2606

Anomalies of dental arch relationship, including avohilmo

408

0.71

1.15

1.2

1.4

419.70

385.95

u/l

0.19

391

Visual disturbances and blindness

282

2511

1.12

1.15

1.3

372.33

500.45

u/l

0.71

264

2382

Behavioural disorders, excluding more controls

2.50

1.15

1.0

1.3

730.00

818.20

u/l

—

Anterior Iridocyclitis

769

1.22

1.13

1.3

372.42

364.09

u/l

0.07

733

Cushing syndrome

2.35

1.13

1.0

1.2

301.86

666.26

u/l

—

Bullous keratopathy

2.29

1.11

1.0

1.5

288.29

245.04

u/l

—

Nonorganic sleeping disorders

610

1.25

1.10

1.4

1.3

400.33

367.26

u/l

0.22

586

Abnormality of red blood cells

2.41

1.09

1.6

1.2

136.40

248.31

u/l

—

Ankle and foot

2.40

1.09

1.4

907.80

247.20

u/l

—

Other abnormal auditory perceptions

2.40

1.09

1.4

1.3

204.20

773.70

u/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

277

1.37

1.09

1.2

1.3

445.07

401.81

u/l

0.15

262

Macular pucker

107

892

1.20

1.08

1.3

274.67

479.21

u/l

1.71

101

839

All anxiety disorders

216

1473

1.14

1.08

1.3

642.45

429.30

u/l

0.95

204

1402

Maternal care for known or suspected abnormality of pelvic organs

206

0.65

1.07

1.2

1.3

347.05

437.00

u/l

0.42

192

Nontoxic multinodular goitre

767

1.21

1.06

1.2

1.3

426.80

374.38

u/l

0.16

732

Spontaneous abortion

725

0.82

1.05

1.2

1.3

441.23

420.31

u/l

0.08

693

Iridocyclitis

107

895

1.20

1.05

1.4

1.3

378.88

376.62

u/l

0.02

851

Polymyalgia rheumatica

705

1.22

1.04

1.1

1.3

704.30

318.79

u/l

0.98

662

Melanocytic naevi

133

1135

1.17

1.04

1.4

1.3

324.75

385.60

u/l

0.81

125

1074

Fibrosis of liver

2.30

1.04

1.4

1.2

508.80

262.15

u/l

—

Benign neoplasm of mouth and pharynx

420

1.29

1.02

1.3

1.4

338.40

331.64

u/l

0.03

402

Other abnormal findings of blood chemistry

171

1.47

1.02

1.3

1.4

403.09

364.86

u/l

0.06

166

Deforming dorsopathies

128

1091

1.17

1.02

1.4

1.3

744.79

400.89

u/l

0.97

121

1051

Gonarthrosis,primary

473

3096

0.92

1.01

1.4

1.3

387.54

492.68

u/l

1.66

451

2928

Varicose veins

354

2431

1.10

1.00

1.4

1.3

354.31

480.98

u/l

1.37

336

2306

Social phobias

1.62

0.99

1.2

1.3

1934.56

445.13

u/l

0.46

Disorders of ocular muscles, binocular movement, accommodation and refraction

192

1676

1.14

0.99

1.4

1.3

695.60

459.51

u/l

0.74

177

1589

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

2.19

0.98

1.0

1.3

258.80

394.87

u/l

—

Other and unspecified rosacea

283

1.35

0.98

1.4

398.24

365.99

u/l

0.12

273

Dermatographic urticaria

159

0.56

0.98

1.4

438.66

382.62

u/l

—

152

Arthrosis

381

1903

1.10

0.98

1.3

463.79

534.66

u/l

0.26

360

1815

Other salmonella infections, including avohilmo

132

1.52

0.97

1.2

1.3

321.94

387.33

u/l

0.20

127

Melanoma in situ of trunk

1.75

0.97

1.4

498.50

250.48

u/l

0.60

Migraine without aura and triptan purchases

236

0.63

0.97

1.5

1.3

388.75

388.10

u/l

0.00

222

Inguinal of femoral hernia, unilateral

108

1.58

0.97

1.4

519.22

368.73

u/l

0.37

103

Inguinal hernia, unilateral

108

1.58

0.97

1.4

519.22

368.73

u/l

0.37

103

Femoral hernia, unilateral

108

1.58

0.97

1.4

519.22

368.73

u/l

0.37

103

Other salmonella infections

116

1.56

0.96

1.2

1.3

249.37

383.88

u/l

0.48

111

Injury of muscle and tendon at shoulder and upper arm level

161

1841

0.87

0.96

1.3

512.98

515.93

u/l

0.01

154

1752

Other strabismus

628

1.22

0.96

1.4

1.3

720.78

370.61

u/l

0.75

602

Other and unspecified psoriasis

250

1.36

0.95

1.2

1.4

268.45

373.99

u/l

0.89

241

Benign lipomatous neoplasm

111

1300

0.85

0.93

1.3

393.92

377.73

u/l

0.09

103

1233

Anxiety disorders, excluding more controls

366

2137

1.09

0.92

1.3

524.58

436.70

u/l

0.49

344

2036

Combined immunodeficiencies

2.16

0.92

1.8

1.3

230.72

284.70

u/l

—

Fracture of skull and facial bones

100

845

1.19

0.91

1.3

843.78

390.08

u/l

0.89

807

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

157

1714

0.88

0.91

1.4

1.3

537.68

399.08

u/l

0.44

150

1629

Female infertility

381

0.79

0.90

1.1

1.3

667.70

486.67

u/l

0.22

363

Alzheimer’s disease (Atypical or mixed)

785

0.81

0.89

1.3

419.63

340.32

u/l

0.33

746

Diseases of the ear and mastoid process

577

2695

1.07

0.88

1.3

516.48

497.56

u/l

0.07

546

2554

Tumor necrosis factor alpha inhibitors

359

1.28

0.88

1.6

1.4

669.59

414.43

u/l

1.40

344

Leiomyoma of uterus

215

1075

1.12

0.87

1.3

315.02

392.33

u/l

1.04

201

1023

Injuries to the wrist and hand

447

3197

0.93

0.87

1.3

651.24

459.41

u/l

0.67

425

3019

Female infertility, cervical, vaginal, other or unspecified origin

368

0.78

0.87

1.1

1.3

748.00

490.66

u/l

0.29

350

Headache

246

1712

1.11

0.87

1.3

338.15

529.67

u/l

2.52

229

1633

Disorders of lacrimal system

220

1942

1.12

0.86

1.3

308.28

448.21

u/l

2.27

204

1844

Hypothyreosis and Thyroxine purchase for inclusion criteria

473

2873

1.08

0.86

1.3

423.41

484.25

u/l

0.24

445

2724

Allergic conjunctivitis

163

1774

0.88

0.86

1.4

1.3

531.29

399.52

u/l

0.44

156

1686

Speech therapy

134

1167

1.15

0.85

1.4

1.3

280.25

376.63

u/l

2.17

126

1098

Sleep disorders (combined)

594

2901

1.07

0.84

1.3

460.92

486.04

u/l

0.08

560

2747

Single delivery by forceps and vacuum extractor

108

0.61

0.84

1.2

1.3

367.27

559.90

u/l

0.55

Arthropathic psoriasis

381

1.26

0.82

1.4

1.3

518.48

377.20

u/l

0.79

368

Disorders of sclera, cornea, iris and ciliary body

264

2402

1.10

0.82

1.4

1.3

352.27

507.49

u/l

2.20

242

2287

Other misadventures during surgical and medical care

1.58

0.81

1.7

1.4

1780.93

459.41

u/l

0.39

Erectile dysfunction

517

1.22

0.81

1.2

1.4

322.85

349.13

u/l

0.14

490

Dislocation, sprain and strain of joints and ligaments of knee

191

1926

0.90

0.80

1.3

566.71

505.07

u/l

0.22

179

1840

Pruritus

400

1.25

0.80

1.3

267.14

324.27

u/l

0.52

384

Acute and subacute iridocyclitis

719

1.18

0.80

1.3

352.70

373.02

u/l

0.20

688

Alzheimer’s disease (Atypical or mixed), excluding more controls

546

0.82

0.79

1.3

438.65

453.83

u/l

0.04

527

Prolapse and hernia of ovary and fallopian tube

162

0.61

0.79

1.3

1.2

187.06

260.86

u/l

—

157

Adhesive capsulitis of shoulder

701

1.19

0.79

1.3

309.05

418.87

u/l

1.16

667

Strabismus

104

893

1.16

0.79

1.3

796.75

365.51

u/l

1.01

844

Pedal cyclist injured in noncollision transport accidents

339

0.74

0.78

1.4

2225.12

376.27

u/l

0.51

323

Seborrhoeic dermatitis

420

1.24

0.78

1.3

315.38

362.24

u/l

0.41

401

Fracture at wrist and hand level

153

1352

1.13

0.77

1.4

1.3

799.84

449.62

u/l

0.58

144

1282

Psoriatic arthropathies

358

1.26

0.77

1.4

1.3

543.77

384.07

u/l

0.87

346

Premature separation of placenta [abruptio placentae]

0.00

0.76

0.0

1.3

—

674.38

—

Other disorders starting during childhood or adolecense, excluding more controls

2.17

0.76

1.4

1.3

502.60

779.26

u/l

—

Melanocytic naevi of ear and external auricular canal

2.11

0.75

1.4

1.3

156.80

590.44

u/l

—

Benign neoplasm of brain and other parts of central nervous system

232

0.69

0.74

1.1

1.4

862.28

364.57

u/l

0.90

224

Conduct disorder

2.09

0.74

1.0

1.3

730.00

739.83

u/l

—

Pediculosis, acariasis and other infestations, including avohilmo

441

1.23

0.74

1.3

1.4

362.34

397.31

u/l

0.26

423

Other enthesopathies

129

1135

1.14

0.74

1.5

1.3

314.12

453.71

u/l

2.27

116

1086

Hypothyroidism, strict autoimmune, 3 medication purchases required

418

2614

1.07

0.74

1.3

452.96

487.45

u/l

0.11

395

2487

Abnormal findings on examination of urine, without diagnosis

167

1.38

0.73

1.3

1.4

242.03

397.62

u/l

1.11

161

Disturbances of skin sensation

102

884

1.15

0.73

1.3

524.75

376.33

u/l

1.21

837

Benign neoplasm: Pharynx, unspecified

2.02

0.73

1.2

201.40

383.73

u/l

—

Panniculitis, unspecified

2.01

0.73

1.2

190.46

292.47

u/l

—

Behavioural disorders

2.01

0.72

1.0

1.3

730.00

747.28

u/l

—

Subjective visual disturbances

116

1016

1.14

0.72

1.3

276.89

392.18

u/l

2.59

107

962

Other disorders starting during childhood or adolescence

1.98

0.72

1.4

1.3

502.60

836.01

u/l

—

Adenocarcinoma and papillary adenocarcinoma of stomach

1.55

0.72

1.2

1.3

388.46

303.29

u/l

0.31

Diseases of inner ear

260

2710

0.92

0.72

1.3

358.54

497.44

u/l

1.87

245

2582

Other disorders of the musculoskeletal system and connective tissue

617

1.19

0.71

1.3

1.4

537.94

342.79

u/l

0.46

589

Other intervertebral disc disorders

431

2398

1.07

0.70

1.4

1.3

410.61

498.89

u/l

0.73

404

2278

Disorders of globe

101

1.49

0.70

1.1

1.3

1662.59

395.76

u/l

0.41

Persons encountering health services in circumstances related to reproduction

152

1141

0.89

0.70

1.4

1.3

332.94

500.16

u/l

3.22

145

1084

Haemorrhoids and perianal venous thrombosis

188

1687

1.11

0.70

1.3

346.63

521.31

u/l

1.87

176

1612

Other symptoms and signs involving the nervous and musculoskeletal systems

199

1807

1.10

0.68

1.3

612.53

489.83

u/l

0.21

187

1715

Disorders of synovium and tendon

210

1954

0.91

0.68

1.4

1.3

482.27

512.90

u/l

0.15

197

1851

Artificial joint operation, meniscal resection

471

3205

0.94

0.68

1.3

448.22

478.15

u/l

0.21

451

3031

Biological medication for rheuma

419

1.22

0.68

1.5

1.3

777.61

413.42

u/l

1.61

402

Additional codes for the location of defect, injury or illness

196

1.33

0.67

1.6

1.3

505.18

378.53

u/l

0.31

189

Urticaria and erythema

137

1220

1.12

0.67

1.3

486.30

372.83

u/l

1.07

127

1157

Excessive attrition of teeth

205

2225

0.91

0.67

1.4

1.3

398.73

521.28

u/l

1.35

193

2119

Lichen simplex chronicus

128

1.41

0.65

1.6

1.3

363.55

441.50

u/l

0.19

123

Left hemicolectomy

103

1.46

0.65

1.3

191.79

306.80

u/l

1.93

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

194

1655

0.91

0.65

1.4

1.3

323.89

459.17

u/l

1.58

180

1573

Extrapyramidal and movement disorders

192

2108

0.91

0.65

1.3

396.82

467.43

u/l

0.53

181

2003

Benign neoplasm: Anus and anal canal

120

1.42

0.64

1.4

1.3

262.03

391.35

u/l

0.75

115

Disorders of breast

153

1211

1.11

0.63

1.3

388.95

388.34

u/l

0.00

142

1153

Pain in joint

278

1578

1.08

0.62

1.4

1.3

447.08

568.16

u/l

0.91

256

1497

Other and unspecified injuries of shoulder and upper arm

104

0.58

0.62

1.2

1.3

333.17

449.37

u/l

—

Diseases of male genital organs

305

1424

1.08

0.62

1.4

1.3

336.19

610.07

u/l

3.53

286

1358

Poor fetal growth

104

0.58

0.61

1.2

1.3

383.50

493.51

u/l

—

Benign neoplasm: Nasopharynx

1.68

0.61

1.6

1.3

696.20

330.04

u/l

—

Injury of nerves at forearm level

1.67

0.61

1.0

1.3

275.60

643.12

u/l

—

severe traumatic brain injury, does not include concussion

147

1324

1.11

0.61

1.3

412.87

419.22

u/l

0.02

141

1254

Visual disturbances

244

2253

1.08

0.60

1.3

398.22

495.92

u/l

0.42

227

2136

Frontotemporal dementia, wide, incl. Pick's disease

0.00

0.60

0.0

1.7

—

324.77

—

Separation of retinal layers (serosa)

138

0.65

0.60

1.3

167.11

430.26

u/l

—

132

Other benign neoplasm of uterus: Corpus uteri

0.00

0.60

0.0

1.1

—

341.01

—

Congenital malformations of uterus and cervix

0.00

0.60

0.0

1.2

—

811.71

—

Hereditary motor and sensory neuropathy

0.00

0.60

0.0

1.3

—

218.46

—

Erythema intertrigo

105

1.43

0.60

1.1

1.3

479.03

409.10

u/l

0.14

100

Recurrent aphthous stomatitis , including avohilmo

490

1.19

0.60

1.3

1.4

454.53

340.62

u/l

0.50

469

Crohn's disease of large intestine

122

1.40

0.60

1.5

1.3

197.18

408.46

u/l

1.57

115

Other and unspecified degenerative diseases of nervous system

151

0.66

0.60

1.3

1.4

186.00

284.29

u/l

—

145

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

197

0.71

0.58

1.5

1.4

327.53

346.69

u/l

0.05

191

Chronic sinusitis

188

1718

1.09

0.58

1.4

1.3

483.86

520.61

u/l

0.15

178

1642

Rotator cuff syndrome

340

2189

1.07

0.58

1.3

436.18

493.49

u/l

0.34

319

2076

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

112

0.62

0.58

1.6

1.3

200.71

360.86

u/l

—

107

Disorders of refraction and accommodation

816

1.14

0.57

1.5

1.3

574.28

388.22

u/l

0.42

778

Severe visual impairment, monocular

1.68

0.57

1.0

1.3

407.67

566.34

u/l

—

Other and unspecified bullous disorders

1.68

0.57

2.0

1.2

345.17

310.09

u/l

—

Keratitis

160

1456

1.10

0.56

1.3

348.77

395.09

u/l

0.43

147

1388

UC patients in KELA-register (code 208), prior to 1994

160

0.69

0.55

1.3

1.4

330.64

389.77

u/l

0.13

151

Polyuria

136

1229

1.11

0.55

1.4

1.3

385.79

444.14

u/l

0.34

127

1164

Benign neoplasm: Skin of lower limb, including hip

1.45

0.55

1.6

1.3

217.46

429.32

u/l

0.95

Recurrent or chronic depression

114

884

0.89

0.55

1.3

752.78

424.29

u/l

0.72

107

846

Disorders of vestibular function (Vertigo)

221

2326

0.92

0.55

1.3

383.00

459.07

u/l

0.70

207

2216

Striking against or struck by other objects

134

1208

1.11

0.55

1.3

592.42

419.27

u/l

0.68

119

1156

Localized swelling, mass and lump of skin and subcutaneous tissue

154

1402

1.10

0.54

1.3

315.68

392.41

u/l

1.15

142

1334

Bicipital tendinitis

159

0.69

0.54

1.1

1.4

324.53

342.14

u/l

0.05

153

Glaucoma

358

2860

1.06

0.54

1.3

485.54

464.33

u/l

0.07

335

2717

Inflammatory disorders of breast

1.42

0.54

1.2

1.4

481.43

418.14

u/l

0.09

Uterine polyps

540

0.88

0.54

1.4

1.2

475.48

410.96

u/l

0.28

515

Other joint disorders

399

1960

1.06

0.54

1.4

1.3

367.81

537.99

u/l

2.34

369

1868

Tularaemia

1.54

0.53

1.2

1.3

290.67

331.34

u/l

—

Contusion of other and unspecified parts of foot

108

1.39

0.53

1.5

1.3

266.80

439.23

u/l

0.77

102

Other disorders of Eustachian tube

1.43

0.53

1.5

1.3

201.25

400.30

u/l

0.98

Crushed, pushed or stepped on by crowd or human stampede

152

1.32

0.52

1.4

1.3

514.60

397.15

u/l

0.34

145

Atopic dermatitis, strict definition with reimbursement

640

1.14

0.51

1.5

1.3

510.07

394.52

u/l

0.80

610

Other diseases of upper respiratory tract

602

2993

1.05

0.51

1.4

1.3

441.28

482.18

u/l

0.32

570

2839

Chondropathies

462

1.17

0.51

1.4

336.18

361.19

u/l

0.18

447

Acute appendicitis, no complications

187

2012

0.92

0.50

1.4

1.3

419.04

560.30

u/l

1.36

179

1905

Conjunctivitis (acute, non atopic)

108

967

1.11

0.50

1.4

1.3

421.52

377.18

u/l

0.33

100

912

Other extrapyramidal and movement disorders in other diseases

106

1177

0.90

0.49

1.3

476.19

373.21

u/l

0.61

100

1114

Speech and linguistic disorders

130

1.33

0.49

1.4

1.3

323.00

435.53

u/l

0.48

125

Oxicams

130

813

0.91

0.49

1.3

553.19

492.62

u/l

0.11

120

770

Outcome of delivery

0.70

0.48

1.2

1.3

341.82

535.21

u/l

0.67

Somatoform disorder

474

1.16

0.48

1.3

1.4

913.86

352.15

u/l

0.60

455

Diseases of tongue

253

1.23

0.48

1.4

1.3

272.05

368.97

u/l

0.77

241

Hypopituitarism

199

1.26

0.47

1.2

1.4

450.12

417.94

u/l

0.13

190

Orchitis and epididymitis

494

1.16

0.47

1.3

383.08

439.45

u/l

0.26

474

Viral warts, including avohilmo

654

1.13

0.46

1.4

1.3

503.10

381.75

u/l

0.32

625

Wet age-related macular degeneration

130

1145

1.10

0.45

1.3

450.65

358.00

u/l

0.27

124

1083

Speech and linguistic disorders, excluding more controls

130

1.30

0.44

1.4

323.00

381.09

u/l

0.21

124

Inflammatory diseases of female pelvic organs

164

1213

0.92

0.44

1.3

410.86

393.62

u/l

0.11

154

1154

Maternal care for other known or suspected fetal problems

138

0.77

0.43

1.6

1.3

349.65

520.24

u/l

0.73

129

Other problems related to primary support group, including family circumstances

179

1.25

0.43

1.2

1.4

510.61

346.53

u/l

0.74

169

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

180

0.80

0.42

1.3

326.30

507.74

u/l

1.14

168

Disorders of psychological development

154

1.26

0.42

1.4

1.3

385.43

426.38

u/l

0.13

147

Neurotic, stress-related and somatoform disorders

370

2421

1.05

0.42

1.3

598.58

480.35

u/l

0.53

348

2299

Postpartum haemorrhage

262

0.82

0.42

1.2

1.3

357.15

482.27

u/l

0.76

246

Irregular menses

749

0.90

0.42

1.4

1.3

350.01

458.85

u/l

0.97

714

Spirochaetal infections, other/unspecified

338

0.83

0.42

1.2

1.4

237.61

356.68

u/l

1.93

324

Premature rupture of membranes

171

0.79

0.41

1.2

1.3

539.57

479.75

u/l

0.14

158

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.00

0.41

0.0

1.3

—

390.20

—

Other disorders of lacrimal gland

169

1571

1.08

0.41

1.3

281.44

401.11

u/l

3.09

156

1494

Abscess of tendon sheath

0.00

0.41

0.0

1.2

—

253.65

—

Congenital malformations of anterior segment of eye

0.00

0.41

0.0

1.1

—

1023.45

—

Other and unspecified neuropathies

0.00

0.41

0.0

1.3

—

249.98

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

0.41

0.0

1.2

—

1092.11

—

Maxillary retrognathism

0.00

0.40

0.0

1.1

—

1156.53

—

Other obstetric conditions, not elsewhere classified

186

0.81

0.40

1.3

450.83

508.14

u/l

0.15

174

Other diseases of hard tissues of teeth

336

1651

1.05

0.40

1.4

1.3

289.46

444.33

u/l

3.48

318

1559

Guttate psoriasis

1.47

0.40

1.4

1.3

236.80

578.07

u/l

—

Inguinal hernia, bilateral

634

1.12

0.40

1.4

1.3

307.51

516.19

u/l

0.99

602

Adrenogenital disorders

0.00

0.40

0.0

1.3

—

222.11

—

Frontotemporal dementia

0.00

0.40

0.0

1.4

—

334.91

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.40

0.0

1.3

—

359.22

—

Cicatricial alopecia [scarring hair loss]

0.00

0.40

0.0

1.3

—

376.74

—

Acetic acid derivatives and related substances

172

826

1.08

0.39

1.3

558.48

493.44

u/l

0.10

160

782

Pedestrian injured in collision with pedal cycle

101

0.69

0.39

1.6

1.3

353.00

398.45

u/l

—

Testicular hypofunction

102

0.68

0.39

1.4

220.71

318.96

u/l

—

Injury of nerves at wrist and hand level

102

0.68

0.39

1.0

1.3

256.00

355.02

u/l

—

Benign neoplasm: Cranial nerves

105

0.66

0.39

1.0

1.4

1675.14

413.13

u/l

—

100

Inguinal or femoral hernia, bilateral

645

1.12

0.39

1.4

1.3

304.75

513.61

u/l

1.01

613

Autism spe

0.00

0.39

0.0

1.2

—

998.63

—

Impingement syndrome of shoulder

112

1027

1.09

0.39

1.3

303.67

545.97

u/l

2.43

102

979

Primary coxarthrosis, bilateral

159

1707

0.93

0.39

1.4

1.3

359.13

449.84

u/l

0.41

151

1618

Vasomotor and allergic rhinitis

108

1150

0.92

0.38

1.4

1.3

713.00

414.04

u/l

0.48

1095

Macular hole

261

1.19

0.38

1.3

347.34

334.07

u/l

0.08

250

Benign neoplasm: Tongue

1.35

0.38

1.3

262.67

324.56

u/l

0.23

Glucosamine medication

260

2190

0.95

0.37

1.4

1.3

275.67

459.84

u/l

3.50

248

2082

Coxibs

169

826

1.07

0.37

1.3

295.57

493.44

u/l

1.31

158

782

Benign neoplasm: Connective and other soft tissue, unspecified

1.36

0.37

1.2

1.3

375.00

310.09

u/l

—

Excessive vomiting in pregnancy

112

0.71

0.37

1.4

1.3

395.38

432.20

u/l

—

106

Other inflammation of eyelid, including avohilmo

144

1547

0.93

0.36

1.3

501.76

435.60

u/l

0.30

139

1472

Gonarthrosis [arthrosis of knee](FG)

394

2168

1.05

0.36

1.3

413.57

529.40

u/l

1.26

372

2058

Otosclerosis

289

0.83

0.36

1.2

1.4

297.58

345.70

u/l

0.29

280

Tongue abnormality

226

1.20

0.35

1.4

259.09

345.69

u/l

0.59

218

Effects of foreign body entering through natural orifice

964

0.91

0.35

1.3

1.4

346.06

395.79

u/l

0.55

927

Sciatica+with lumbago

220

2060

0.94

0.35

1.3

392.64

504.23

u/l

1.10

207

1965

Spondylosis

299

2225

1.05

0.35

1.3

528.67

487.36

u/l

0.20

279

2119

Other disorders of eyelid

270

2422

1.05

0.34

1.3

299.79

474.74

u/l

2.91

258

2301

Hallux rigidus

627

0.89

0.34

1.4

1.3

351.27

393.98

u/l

0.30

602

Other disorders of binocular movement

1.37

0.34

1.2

1.3

445.00

486.08

u/l

—

Congenital deformities of feet

1.37

0.34

1.3

1.4

319.65

609.30

u/l

—

Unspecified urinary incontinence

339

1.15

0.34

1.4

1.3

438.58

346.41

u/l

0.16

328

Urolithiasis

169

1798

0.94

0.34

1.4

1.3

403.63

537.77

u/l

0.68

160

1709

Fall on same level involving ice and snow

275

2620

1.05

0.33

1.3

412.91

517.61

u/l

0.49

259

2490

Organic, including symptomatic, mental disorders

363

2448

1.04

0.32

1.2

1.4

458.63

433.98

u/l

0.10

340

2330

Nontoxic goitre/thyroid nodule

128

1193

1.07

0.32

1.3

378.27

364.00

u/l

0.05

122

1128

Primary hyperparathyroidism

417

1.13

0.32

1.2

1.4

254.10

334.73

u/l

0.64

398

Anxiety disorders

374

2463

1.04

0.31

1.3

595.38

476.00

u/l

0.55

352

2340

Inflammatory bowel disease

124

1156

1.07

0.31

1.4

1.3

318.81

393.20

u/l

1.19

119

1099

Gonarthrosis

344

1862

1.04

0.31

1.3

414.82

519.61

u/l

0.99

322

1778

Rosacea

408

1.13

0.31

1.5

1.4

391.61

347.09

u/l

0.21

390

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

994

0.92

0.31

1.3

367.54

430.13

u/l

0.53

945

Perineal laceration during delivery

124

0.78

0.31

1.3

406.08

516.26

u/l

0.40

113

Other congenital malformations of skin

0.72

0.31

1.4

1.3

302.00

451.99

u/l

—

Mood [affective] disorders

449

2976

0.97

0.30

1.3

590.62

481.67

u/l

0.65

423

2821

Blepharochalasis

159

1499

1.06

0.30

1.3

355.73

438.44

u/l

0.55

153

1420

Calculus of kidney and ureter

152

1612

0.94

0.29

1.4

1.3

318.38

514.72

u/l

2.32

144

1535

Redundant prepuce, phimosis and paraphimosis

104

953

1.07

0.28

1.4

1.3

662.15

646.42

u/l

0.02

915

Mood disorders

452

2986

0.97

0.28

1.3

589.11

480.64

u/l

0.66

426

2829

Glaucoma, exfoliation

603

1.10

0.28

1.3

1202.63

303.70

u/l

0.98

570

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

1.27

0.28

1.0

1.3

298.25

280.47

u/l

—

Ménière disease

384

1.12

0.27

1.3

1.4

330.95

327.72

u/l

0.02

370

Early lumbar disc prolapse operation

168

1.19

0.27

1.4

1.3

617.10

446.85

u/l

0.47

161

Meniscus derangement

261

1805

0.96

0.26

1.3

436.06

527.02

u/l

0.46

244

1723

Allergic rhinitis

699

0.92

0.26

1.4

1.3

980.99

395.41

u/l

0.59

670

Macular cyst

149

0.80

0.26

1.2

1.3

294.17

350.99

u/l

0.15

143

Antenatal screening

144

0.85

0.25

1.2

382.14

467.09

u/l

0.29

133

Other specific joint derangements/joint disorders

309

1854

1.04

0.25

1.4

1.3

431.22

547.15

u/l

1.02

286

1766

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

114

1.23

0.25

1.6

1.3

508.49

428.27

u/l

0.16

108

Mucosal proctocolitis

361

0.89

0.24

1.3

1.4

315.16

390.40

u/l

0.47

344

Excessive, frequent and irregular menstruation

101

576

0.94

0.24

1.4

1.2

286.53

414.65

u/l

1.60

548

Fibromyalgia

191

0.84

0.24

1.3

1.2

461.94

364.33

u/l

0.22

184

Other headache syndromes

146

1532

0.95

0.24

1.3

362.17

441.91

u/l

0.57

131

1469

Vascular dementia (multiple infarctions)

0.71

0.24

1.2

1.4

328.83

246.60

u/l

—

Other benign neoplasms of skin

192

1836

1.05

0.24

1.3

402.93

436.47

u/l

0.20

186

1743

Mood disorders, excluding more controls

441

2515

1.03

0.23

1.3

526.85

440.99

u/l

0.68

416

2394

Unspecified dementia

705

0.93

0.23

1.2

1.4

629.86

348.26

u/l

0.61

668

Open wound of wrist and hand

179

1809

0.96

0.23

1.3

801.59

499.13

u/l

0.54

172

1712

Endometriosis diagnosis and infertility diagnosis occurring together

143

1.19

0.23

1.2

1.3

358.62

449.07

u/l

0.49

135

Pigmented purpuric dermatosis

1.29

0.23

1.2

95.40

531.83

u/l

—

Selective serotonin reuptake inhibitors

512

2590

1.03

0.23

1.3

546.41

457.94

u/l

0.38

484

2460

Other noninflammatory disorders of uterus, except cervix

523

1.07

0.22

1.2

332.05

399.91

u/l

0.33

502

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

100

815

1.06

0.22

1.4

1.3

308.79

438.04

u/l

1.43

778

Oter anti-inflammatory and antirheumatic agents, non-steroids

153

800

1.05

0.22

1.4

1.3

304.79

492.38

u/l

1.14

148

758

Coxarthrosis, primary, with hip surgery

279

2675

0.97

0.21

1.4

1.3

361.95

482.58

u/l

1.01

263

2538

Fibrothorax

0.00

0.21

0.0

1.3

—

320.76

—

Congenital retinoschisis

0.00

0.21

0.0

1.2

—

216.10

—

Urticaria

894

1.06

0.21

1.3

467.97

360.47

u/l

0.84

845

Small kidney of unknown cause

0.00

0.21

0.0

1.2

—

283.67

—

Accidental poisoning by and exposure to pesticides

0.00

0.21

0.0

1.1

—

282.37

—

Carcinoma in situ of lip, oral cavity and pharynx

0.00

0.21

0.0

1.2

—

350.66

—

Congenital retinoschisis

0.00

0.21

0.0

1.2

—

216.10

—

Other obstructed labour

124

0.81

0.21

1.8

1.3

158.60

519.20

u/l

—

118

Injury of blood vessels at forearm level

0.00

0.21

0.0

1.5

—

158.00

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

0.21

0.0

1.2

—

214.16

—

Retrobulbar neuritis in diseases classified elsewhere

0.00

0.21

0.0

1.2

—

1203.50

—

Qualitative platelet defects

0.00

0.21

0.0

1.1

—

1183.17

—

Other congenital malformations of kidney

0.00

0.21

0.0

1.1

—

252.85

—

Yaws, including avohilmo

0.00

0.21

0.0

1.3

—

296.20

—

Sequelae of burns, corrosions and frostbite

0.00

0.21

0.0

1.3

—

270.30

—

Chloasma

0.00

0.21

0.0

1.1

—

208.09

—

Mastocytosis

0.00

0.21

0.0

1.3

—

250.86

—

Maxillary prognathism

0.00

0.21

0.0

1.1

—

509.70

—

Superficial injury of ankle and foot, unspecified

0.00

0.21

0.0

1.0

—

1169.66

—

Carcinoma in situ of uteri, other/unspecified

0.00

0.21

0.0

1.0

—

1155.57

—

Follicular adenocarcinoma of thyroid gland

0.00

0.21

0.0

1.2

—

384.73

—

Carcinoma in situ of cervix uteri, exocervix

0.00

0.21

0.0

1.0

—

1277.77

—

Endometriosis of fallopian tube

0.00

0.21

0.0

1.0

—

1247.90

—

Disorders in reading

0.00

0.21

0.0

1.1

—

1339.73

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

0.21

0.0

1.5

—

162.55

—

Oesophagitis, drug-induced

0.00

0.21

0.0

1.3

—

251.75

—

Bradycardia, unspecified, drug-induced

0.00

0.21

0.0

1.3

—

243.30

—

Sequelae of inflammatory diseases of the central nervous system

0.00

0.21

0.0

1.3

—

253.89

—

Melanoma in situ, other sites/unspecified

0.00

0.21

0.0

1.4

—

183.80

—

Other disorders following mastoidectomy

0.00

0.21

0.0

1.3

—

210.55

—

Benign intracranial hypertension

0.00

0.21

0.0

1.3

—

1115.17

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

0.00

0.21

0.0

1.1

—

1196.83

—

Other congenital malformations of ear

0.00

0.21

0.0

1.3

—

1108.55

—

Disorders of puberty, all

0.00

0.21

0.0

1.3

—

518.13

—

Ovarian hyperstimulation (induction)

0.00

0.21

0.0

1.3

—

1072.17

—

Autism spe, excluding more controls

0.00

0.21

0.0

1.2

—

1091.08

—

Other sudden death, cause unknown

0.00

0.21

0.0

1.4

—

201.77

—

Choroidal haemorrhage and rupture

0.00

0.21

0.0

1.4

—

305.51

—

Use of riluzole

0.00

0.21

0.0

1.3

—

351.21

—

Accidental poisoning by and exposure to other gases and vapours

0.00

0.21

0.0

1.2

—

358.18

—

Benign neoplasm: Skin of ear and external auricular canal

173

1.16

0.21

1.4

1.3

629.10

384.82

u/l

0.38

167

Scarlet fever

0.00

0.21

0.0

1.2

—

306.36

—

Other and unspecified injuries of forearm

0.00

0.21

0.0

1.3

—

936.23

—

Benign leiomyoma with endometriosis

481

0.91

0.21

1.4

1.3

296.04

377.38

u/l

0.63

457

Open bite that required surgery (Lefort1 or BSSO)

0.00

0.21

0.0

1.2

—

1053.15

—

Postpartum hemorraghe, all women as controls

286

0.89

0.21

1.2

1.3

357.15

489.22

u/l

0.84

266

Artificial joint re-operation

306

1.11

0.21

1.5

1.4

305.82

291.70

u/l

0.06

296

Deviated nasal septum

149

1557

0.96

0.20

1.3

606.31

541.20

u/l

0.21

137

1483

Menorrhagia

108

569

1.06

0.20

1.5

1.2

306.20

408.24

u/l

1.02

103

542

Dyslexia and other symbolic dysfunctions, not elsewhere classified

0.00

0.20

0.0

1.2

—

960.31

—

Other dermatomyositis

0.00

0.20

0.0

1.1

—

960.97

—

Postinfectious hypothyroidism

0.00

0.20

0.0

1.1

—

892.26

—

Psoas tendinitis

0.00

0.20

0.0

1.2

—

911.62

—

Other and unspecified papulosquamous disorders

0.00

0.20

0.0

1.3

—

334.48

—

Pedal cyclist injured in collision with pedestrian or animal

0.00

0.20

0.0

1.5

—

405.09

—

Unequal limb length (acquired)

0.00

0.20

0.0

1.1

—

1077.71

—

Galactorrhea

0.00

0.20

0.0

1.2

—

987.81

—

Dermatophytosis, including avohilmo

306

2908

1.03

0.20

1.3

584.91

480.73

u/l

0.20

292

2756

Prolonged pregnancy

124

1.17

0.19

1.2

1.3

710.76

500.55

u/l

0.50

115

Atrophic disorders of skin

500

0.92

0.19

1.5

1.3

420.11

345.64

u/l

0.28

477

D07AA Corticosteroids, weak (group I)

393

1.09

0.19

1.2

1.4

370.74

362.17

u/l

0.04

378

Diseases of middle ear and mastoid

212

1668

1.04

0.19

1.3

493.16

486.69

u/l

0.02

204

1578

Carpal tunnel syndrome

276

2465

0.97

0.19

1.4

1.3

352.21

518.39

u/l

1.87

256

2348

Nonspecific lymphadenitis

143

0.84

0.18

1.8

1.4

221.08

389.89

u/l

1.14

136

Other arthrosis

273

1773

1.03

0.18

1.4

1.3

582.18

527.75

u/l

0.12

252

1692

Other degenerative diseases of the nervous system

165

1156

1.04

0.18

1.2

1.3

834.89

478.27

u/l

0.56

154

1115

Depression or dysthymia

339

1801

1.03

0.18

1.4

1.3

497.23

463.51

u/l

0.16

319

1713

Cervical disc disorders

165

1714

0.96

0.18

1.4

1.3

390.34

511.56

u/l

0.96

154

1637

Ulcerative colitis, NAS

435

1.08

0.17

1.3

369.38

376.36

u/l

0.04

417

Female infertility, associated with anovulation

1.15

0.17

1.0

1.2

600.86

596.20

u/l

—

Trigger finger

513

1.07

0.17

1.4

1.3

397.09

394.02

u/l

0.01

490

Melanocytic naevi of scalp and neck

0.75

0.17

1.4

1.3

205.20

486.37

u/l

—

Calcific tendinitis of shoulder

173

0.87

0.16

1.3

240.40

356.94

u/l

0.88

167

Undefined dementia

712

0.95

0.16

1.2

1.3

629.86

347.87

u/l

0.61

668

Total colectomy operation

139

1.15

0.16

1.1

1.3

520.13

412.45

u/l

0.24

133

Total colectomy

139

1.15

0.16

1.1

1.3

520.13

412.45

u/l

0.24

133

Spontaneous rupture of synovium and tendon

321

1.09

0.16

1.5

1.3

473.10

340.67

u/l

0.51

308

Postpartum haemorrhage due to retained placenta

119

0.84

0.15

1.3

1.4

288.90

400.88

u/l

—

113

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

161

0.87

0.15

1.2

1.4

787.43

310.11

u/l

0.51

153

Injury of muscle and tendon at hip and thigh level

338

0.92

0.15

1.7

1.4

278.25

365.71

u/l

0.72

325

Other disorders of cornea

371

1.08

0.15

1.3

1.4

440.50

344.40

u/l

0.25

359

Memory loss

469

1.07

0.14

1.3

1.4

630.00

310.68

u/l

0.54

445

Pregnancy with abortive outcome

192

1031

0.97

0.14

1.3

448.82

377.29

u/l

0.27

182

979

Testicular dysfunction

118

0.85

0.14

1.3

1.4

654.80

364.54

u/l

—

113

Foreign body or object entering through skin

181

0.88

0.14

1.2

1.4

523.80

414.36

u/l

0.49

172

Medical treatment for female infertility

206

1.11

0.14

1.2

1.3

1127.30

498.94

u/l

0.39

192

Nontraumatic intracranial haemmorrhage

117

1126

1.04

0.14

1.4

1.3

363.93

429.97

u/l

0.46

111

1068

Necrosis of pulp, including avohilmo

210

2131

0.97

0.13

1.3

531.61

520.59

u/l

0.03

199

2023

Hyperkinetic disorders

0.80

0.13

1.1

1.2

726.13

565.57

u/l

—

Temporal arteritis

170

1.12

0.13

1.4

1.3

413.05

258.52

u/l

0.70

164

Excessive earwax

335

3096

0.98

0.13

1.3

322.05

494.79

u/l

3.67

316

2934

Endovascular or surgical operations to intracerebral aneurysms

209

1.10

0.13

1.2

1.4

401.50

366.19

u/l

0.13

200

Other disorders of amniotic fluid and membranes

123

0.86

0.13

1.5

1.3

329.91

497.99

u/l

0.72

112

Retinal breaks without detachment

683

0.95

0.13

1.3

355.95

386.21

u/l

0.21

649

Lesion of ulnar nerve

560

1.05

0.12

1.6

1.3

347.30

386.14

u/l

0.24

540

Disorders of vitreous body and globe

271

2507

1.02

0.12

1.3

434.53

491.59

u/l

0.25

258

2385

Other diseases of lip and oral mucosa

177

1723

1.03

0.12

1.3

439.30

417.41

u/l

0.18

169

1648

Giant cell arteritis with polymyalgia rheumatica

172

1.11

0.11

1.4

1.3

413.05

257.69

u/l

0.70

166

Contact with heat and hot substances

153

1.11

0.11

1.2

1.3

162.31

407.95

u/l

2.61

147

Erosion of teeth , including avohilmo

781

0.96

0.11

1.5

1.3

438.79

382.18

u/l

0.36

740

Polycystic ovarian syndrome, broad definition

1.16

0.11

1.0

1.4

568.70

503.15

u/l

—

Acute appendicitis

292

2659

1.02

0.10

1.4

1.3

377.49

532.14

u/l

2.38

280

2521

Ulcerative proctitis

173

1.10

0.10

1.4

292.89

366.46

u/l

0.31

164

Artrosis, including avohilmo

427

2370

0.99

0.09

1.3

479.43

498.46

u/l

0.07

405

2249

Acute alcohol intoxication ICD-9

145

0.90

0.09

1.3

1.4

479.00

335.28

u/l

0.44

139

Patent foramen ovale

1.04

0.09

1.2

1.4

536.10

527.94

u/l

—

Use of pramipexole

107

1040

1.03

0.09

1.4

1.3

324.51

348.59

u/l

0.21

100

988

Polyp of the female genital tract

555

0.97

0.09

1.4

1.2

430.17

408.54

u/l

0.09

528

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

120

1231

0.97

0.08

1.4

1.3

464.51

416.79

u/l

0.18

110

1171

Other/unspecified disorders of vestibular function

175

0.91

0.08

1.5

1.3

198.52

369.13

u/l

1.61

167

Internal derangement of knee

158

1598

0.98

0.08

1.4

1.3

438.15

544.35

u/l

0.36

148

1526

Glaucoma suspect

190

1935

0.98

0.08

1.3

370.71

450.84

u/l

0.34

181

1838

Dislocation, sprain and strain of joints and ligaments of head

0.85

0.07

1.1

1.2

220.56

330.57

u/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

163

0.92

0.07

1.3

321.00

370.64

u/l

0.14

157

Post-traumatic wound infection, not elsewhere classified

0.88

0.06

1.5

1.3

420.46

297.45

u/l

—

Disturbance of activity and attention

0.88

0.06

1.1

1.2

726.13

561.89

u/l

—

Multiple gestation

0.87

0.06

1.1

1.3

275.38

502.25

u/l

—

Mouth breathing

173

1698

1.02

0.06

1.3

412.39

539.58

u/l

0.90

157

1624

Other keratitis

354

1.05

0.06

1.2

1.4

322.18

356.35

u/l

0.19

342

Certain zoonotic bacterial diseases, including avohilmo

1.11

0.06

1.4

1.3

321.64

321.25

u/l

0.00

Other degenerative diseases of the basal ganglia

100

0.90

0.06

1.1

1.4

269.44

319.51

u/l

—

Transport accidents

181

1482

1.02

0.06

1.4

1.3

636.31

461.49

u/l

0.29

172

1405

Maternal care for known or suspected fetal abnormality and damage

120

0.92

0.06

1.3

570.31

535.18

u/l

0.06

110

Carcinoma in situ of cervix uteri

129

1.09

0.05

1.1

1.3

335.91

423.83

u/l

0.25

123

Toxic effect of contact with venomous animals

120

0.92

0.05

1.3

631.45

426.58

u/l

0.31

115

Abnormal spermatozoa

814

1.02

0.04

1.5

1.3

262.82

482.32

u/l

1.71

775

Postpartum hemorraghe, parous women as controls

227

0.96

0.04

1.2

1.3

357.15

416.66

u/l

0.32

216

Cystitis

421

2519

0.99

0.04

1.3

361.89

507.89

u/l

2.12

401

2396

Ectopic pregnancy

341

0.97

0.03

1.4

1.3

824.00

452.89

u/l

0.55

325

Mixed and other personality disorders

151

1.06

0.03

1.1

1.4

3234.94

413.04

u/l

0.49

141

Symptoms and signs involving speech and voice

158

1564

1.01

0.03

1.4

1.3

493.42

408.87

u/l

0.44

152

1482

Flat foot [pes planus] (acquired)

330

1.03

0.03

1.3

702.83

408.40

u/l

0.66

317

Migraine with aura

561

0.98

0.03

1.4

1.3

307.03

422.19

u/l

1.54

539

Personal history of malignant neoplasm

232

1.03

0.02

1.6

1.3

342.46

389.62

u/l

0.25

221

Medical abortion

189

1016

1.01

0.02

1.3

431.48

380.30

u/l

0.19

182

965

Primary open-angle glaucoma

201

1944

0.99

0.01

1.3

579.01

421.96

u/l

0.41

189

1843

Disorders of vitreous body

257

2455

1.00

0.01

1.3

357.52

479.76

u/l

1.59

244

2337

Appendicitis, broad definition

312

2786

1.00

0.01

1.5

1.3

372.30

536.34

u/l

2.78

300

2639

Diseases of appendix

316

2813

1.00

0.01

1.5

1.3

371.00

533.91

u/l

2.79

303

2664

Primary open-angle glaucoma, strict

159

1595

0.99

0.01

1.3

390.01

435.07

u/l

0.14

151

1509

Anti-inflammatory and antirheumatic products, non-steroids

164

829

0.99

0.01

1.3

409.32

492.82

u/l

0.31

159

785

Benign neoplasm: Other and unspecified parts of mouth

114

1.05

0.00

1.5

1.3

246.08

399.00

u/l

0.76

108

Seborrhoeic keratosis

126

1267

0.99

0.00

1.4

1.3

609.30

378.08

u/l

0.69

119

1209

Lumbar disc prolapse

300

2216

1.00

0.00

1.4

1.3

440.28

512.68

u/l

0.53

282

2109

Cramp and spasm

149

1.01

0.00

1.6

1.3

307.73

381.45

u/l

0.32

144

Other disorders of conjunctiva

682

1.00

0.00

1.5

1.3

319.21

352.52

u/l

0.29

646

Supervision of normal pregnancy

138

0.99

0.00

1.2

248.38

469.10

u/l

1.85

127

Benign neoplasm: Kidney

136

1.03

0.00

1.6

1.4

690.14

292.95

u/l

0.62

130

Inflammatory diseases of prostate (prostatitis)

755

1.01

0.00

1.5

1.3

319.82

614.36

u/l

2.05

730

Coxarthrosis, primary

362

3003

1.00

0.00

1.4

1.3

350.81

480.26

u/l

1.49

345

2842

Intracerebral haemorrhage

726

1.01

0.00

1.2

1.3

385.96

406.14

u/l

0.08

687

Other specified and unspecified retinal disorders

142

0.99

0.00

1.5

1.3

115.93

386.68

u/l

3.12

136

Lateral epicondylitis

393

0.99

0.00

1.6

1.3

356.43

411.22

u/l

0.34

380

Ulcerative rectosigmoiditis

241

1.00

0.00

1.3

1.4

323.42

382.93

u/l

0.35

228

Other specified and unspecified disorders of eye and adnexa

123

0.98

0.00

1.1

1.3

219.27

389.50

u/l

0.92

118

Depression

411

2746

1.00

0.00

1.3

605.15

479.84

u/l

0.72

388

2602

Other appendicitis

247

1.01

0.00

2.0

1.4

290.88

378.12

u/l

0.63

237

Benign neoplasm of thyroid gland

105

0.95

0.00

1.6

1.2

437.30

397.13

u/l

—

Neuroendocrine tumor and carcinoma of stomach

0.00

0.0

1.3

—

380.89

—

Reduction defects of upper limb

0.00

0.0

1.2

—

324.20

—

Hypospadias

0.00

0.0

1.5

—

481.50

—

Other superficial injuries of ankle and foot

0.00

0.0

1.2

—

477.92

—

Intermittent hydrarthrosis

0.00

0.0

1.0

—

211.83

—

Unspecified contact dermatitis due to drugs in contact with skin

0.00

0.0

1.0

—

261.92

—

Diffuse (eosinophilic) fasciitis

0.00

0.0

1.1

—

200.79

—

Explosion of other materials

0.00

0.0

1.4

—

224.43

—

Murder, homicide, or other assault by rifle, shotgun and larger firearm discharge

0.00

0.0

1.2

—

364.17

—

Photocontact dermatitis [berloque dermatitis]

0.00

0.0

1.1

—

226.95

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

0.0

1.1

—

220.92

—

Sexual assault by bodily force

0.00

0.0

1.2

—

276.20

—

Mechanical strabismus

0.00

0.0

1.2

—

294.08

—

Acanthosis nigricans

0.00

0.0

1.1

—

1314.33

—

Pre-eclampsia superimposed on chronic hypertension

0.00

0.0

1.0

—

2205.20

—

Thyroid crisis or storm

0.00

0.0

1.0

—

218.27

—

Diseases of thymus

0.00

0.0

1.2

—

206.80

—

Lymphocyte function antigen-1 [LFA-1] defect

0.00

0.0

1.3

—

176.80

—

Carcinoma in situ of oral cavity and pharynx

0.00

0.0

1.1

—

182.70

—

Carcinoma in situ of lip

0.00

0.0

1.4

—

203.00

—

Benign neoplasm: Lymph nodes

0.00

0.0

1.3

—

1415.00

—

Enterobiasis

0.00

0.0

1.2

—

263.60

—

Relapsing fevers, including avohilmo

0.00

0.0

1.3

—

217.63

—

Congenital syphilis, including avohilmo

0.00

0.0

1.2

—

194.80

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

-0.00

0.0

1.2

—

217.93

—

Total (external) ophthalmoplegia

0.00

-0.00

0.0

1.2

—

313.80

—

Other hypertrichosis

0.00

-0.00

0.0

1.0

—

1803.28

—

Complications specific to multiple gestation

0.00

-0.00

0.0

1.2

—

1932.27

—

Pelvic region

0.00

-0.00

0.0

1.2

—

197.93

—

Disorders of other digestive organs in diseases classified elsewhere

0.00

-0.00

0.0

1.4

—

273.57

—

Whooping cough

0.00

-0.00

0.0

1.1

—

1434.75

—

Degenerative and vascular disorders of ear

0.00

-0.00

0.0

1.1

—

322.96

—

Juvenile Open Angle Glaucoma

0.00

-0.00

0.0

1.2

—

235.89

—

Vitreous prolapse

0.00

-0.00

0.0

1.4

—

207.39

—

Mandibular prognathia AND surgery (LeFortI or BSSO)

0.00

-0.00

0.0

1.2

—

2188.40

—

Acrodermatitis chronica atrophicans

0.00

-0.00

0.0

1.0

—

276.92

—

Polyp of middle ear

0.00

-0.00

0.0

1.1

—

201.94

—

Onychogryphosis

0.00

-0.00

0.0

1.3

—

226.54

—

Phantom limb syndrome

0.00

-0.00

0.0

1.4

—

122.00

—

Myotonic dystrophy (Steinert)

0.00

-0.00

0.0

1.1

—

318.29

—

Other changes in lacrimal passages

0.00

-0.00

0.0

1.0

—

246.67

—

Nonadministration of surgical and medical care

0.00

-0.00

0.0

1.4

—

272.57

—

Trachoma

0.00

-0.00

0.0

1.2

—

338.20

—

Multiple system atrophy (rare forms of Parkinsonism)

0.00

-0.00

0.0

1.4

—

176.11

—

Disorders of olfactory nerve

0.00

-0.00

0.0

1.2

—

275.80

—

Disorders of puberty, other/unspecified

0.00

-0.00

0.0

1.2

—

269.74

—

Compression of brain

0.00

-0.00

0.0

1.2

—

293.67

—

Lichen planopilaris

0.00

-0.00

0.0

1.3

—

193.93

—

Accessory breast

0.00

-0.00

0.0

1.0

—

1472.25

—

Disorders of glossopharyngeal nerve

0.00

-0.00

0.0

1.1

—

253.86

—

Severe bullous disorders, KELA reimbursement

0.00

-0.00

0.0

1.2

—

290.45

—

Congenital hydrocephalus

0.00

-0.00

0.0

1.5

—

220.00

—

Intentional self-harm by smoke, fire and flames

0.00

-0.00

0.0

1.2

—

338.20

—

Hyperalimentation, other specified

0.00

-0.00

0.0

1.2

—

141.38

—

Prominent ears

0.00

-0.00

0.0

1.2

—

1390.40

—

Multiple superficial injuries of ankle and foot

0.00

-0.00

0.0

1.2

—

271.00

—

Pervasive developmental disorders excl. Autism + Asperger

0.00

-0.00

0.0

1.3

—

1746.88

—

Ototoxic hearing loss

0.00

-0.00

0.0

1.4

—

294.20

—

Social disorders starting during childhood or adolescence

0.00

-0.00

0.0

1.2

—

2640.00

—

Toxic erythema

0.00

-0.00

0.0

1.3

—

185.27

—

Dengue fever [classical dengue]

0.00

-0.00

0.0

1.2

—

364.17

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

-0.00

0.0

1.3

—

272.80

—

Inflammation of lacrimal passages (acute and unspecified)

0.89

-0.00

1.0

1.3

152.60

493.13

u/l

—

Lens-induced iridocyclitis

0.00

-0.00

0.0

1.5

—

221.91

—

Eosinophilic cellulitis [Wells]

0.00

-0.00

0.0

1.2

—

210.00

—

Colour vision deficiencies

0.00

-0.00

0.0

1.3

—

238.84

—

Alopecia universalis

0.00

-0.00

0.0

1.1

—

329.51

—

Gastroenterology and urology devices associated with adverse incidents

0.00

-0.00

0.0

1.2

—

263.92

—

Neurofibromatosis, type 2

0.00

-0.00

0.0

1.1

—

335.71

—

Relapsing fevers

0.00

-0.00

0.0

1.3

—

217.63

—

Precocious central puberty

0.00

-0.00

0.0

1.1

—

1527.34

—

Cutaneous autosensitization

0.00

-0.00

0.0

1.2

—

343.80

—

Obstetric embolism

0.00

-0.00

0.0

1.0

—

309.72

—

Other and unspecified water transport accidents

0.00

-0.00

0.0

1.1

—

531.43

—

Esophageal diverticulum (pouch)

0.00

-0.00

0.0

1.6

—

379.18

—

Pituitary-dependent Cushing's disease

0.00

-0.00

0.0

1.2

—

226.14

—

Poikiloderma of Civatte

0.00

-0.00

0.0

1.1

—

297.24

—

Actinic reticuloid

0.00

-0.00

0.0

1.5

—

133.83

—

Unspecified hairloss

0.00

-0.00

0.0

1.4

—

285.14

—

Exposure to ignition or melting of other clothing and apparel

0.00

-0.00

0.0

1.4

—

268.00

—

Fall involving playground equipment

0.00

-0.00

0.0

1.3

—

1587.37

—

Neuromyelitis optica

0.00

-0.00

0.0

1.0

—

276.80

—

Phantom limb syndrome with pain

0.00

-0.00

0.0

1.4

—

178.14

—

Polyglandular dysfunction, other/unspecified

0.00

-0.00

0.0

1.0

—

2207.54

—

Hypertrophy of bone

0.00

-0.00

0.0

1.0

—

210.92

—

Bicornuate uterus

0.00

-0.00

0.0

1.0

—

1509.20

—

Hypothyroidism, autoimmune, DX-based

0.00

-0.00

0.0

1.1

—

275.57

—

Drug-induced fever

0.00

-0.00

0.0

1.3

—

195.00

—

Hypervitaminosis D

0.00

-0.00

0.0

1.2

—

250.14

—

General hospital and personal-use devices associated with adverse incidents

0.00

-0.00

0.0

1.6

—

213.00

—

Discharge from other and unspecified firearms

0.00

-0.00

0.0

1.1

—

275.71

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.00

-0.00

0.0

1.4

—

978.20

—

Sunburn

0.00

-0.00

0.0

1.0

—

279.34

—

Drug-induced aplastic anaemia

0.00

-0.00

0.0

1.2

—

173.50

—

0.00

-0.00

0.0

1.1

—

1316.44

—

Congenital syphilis

0.00

-0.00

0.0

1.2

—

194.80

—

Other porphyria

0.00

-0.00

0.0

1.0

—

335.24

—

Unicornuate uterus

0.00

-0.00

0.0

1.0

—

2204.40

—

Other inflammation of vagina/vulva

0.91

-0.00

1.0

1.2

954.00

566.07

u/l

—

Duodenal ulcer - Chronic without haemorrhage or perforation, drug-induced

0.00

-0.00

0.0

1.0

—

332.67

—

Other congenital malformations of male genital organs

0.00

-0.00

0.0

1.1

—

581.00

—

Carcinoma in situ of oral cavity

0.00

-0.00

0.0

1.2

—

168.73

—

Osteochondrosis of ankle, juvenile

0.00

-0.00

0.0

1.2

—

1360.40

—

Hyperkinetic disorders, excluding more controls

0.90

-0.00

1.1

1.2

726.13

611.30

u/l

—

Benign neoplasm: Urethra

0.00

-0.00

0.0

1.3

—

206.33

—

Congenital ovarian cysts

0.91

-0.00

1.6

1.3

223.60

549.34

u/l

—

Assault by hanging, strangulation and suffocation

0.00

-0.00

0.0

1.0

—

342.50

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

-0.00

0.0

1.2

—

115.32

—

Benign neoplasm: Female genital organ, unspecified

0.00

-0.00

0.0

1.0

—

277.00

—

Flexion deformity

0.00

-0.00

0.0

1.0

—

211.74

—

Tracheo-bronchomalasia

0.00

-0.00

0.0

1.2

—

2159.83

—

Other specified acquired deformities of limbs

0.00

-0.00

0.0

1.0

—

1251.41

—

Osteolysis

0.00

-0.00

0.0

1.4

—

141.52

—

Twin gestation

0.90

-0.00

1.1

1.3

275.38

504.56

u/l

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

-0.00

0.0

1.0

—

333.27

—

Knuckle pads

0.00

-0.00

0.0

1.6

—

201.20

—

Familial benign pemphigus (Hailey-Hailey disease)

0.00

-0.00

0.0

1.3

—

198.24

—

Traumatic spondylopathy

0.00

-0.00

0.0

1.5

—

136.21

—

Interstitial myositis

0.00

-0.00

0.0

1.2

—

251.34

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.92

-0.00

1.0

1.3

178.86

443.82

u/l

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

-0.00

0.0

1.1

—

219.75

—

Primary amenorrhea

0.00

-0.00

0.0

1.2

—

1888.67

—

Toxic encephalopathy

0.00

-0.00

0.0

1.3

—

197.66

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

-0.00

0.0

1.2

—

313.83

—

Adenocarcinoma of small intestine

0.00

-0.00

0.0

1.3

—

207.29

—

Injury of blood vessels at hip and thigh level

0.00

-0.00

0.0

1.4

—

262.70

—

Injury of muscle and tendon at neck level

0.00

-0.00

0.0

1.4

—

220.60

—

Acute lymphocytic leukaemia, including Hilmo

0.00

-0.00

0.0

1.1

—

491.14

—

Operations 1 for CAVS

0.00

-0.00

0.0

1.3

—

320.10

—

Injury of blood vessels at shoulder and upper arm level

0.00

-0.00

0.0

1.2

—

298.17

—

Acute lymphocytic leukaemia

0.00

-0.00

0.0

1.1

—

491.14

—

Trachoma, including avohilmo

0.00

-0.00

0.0

1.2

—

338.20

—

Complications of anaesthesia during the puerperium

0.00

-0.00

0.0

1.0

—

2204.40

—

Injury of heart

0.00

-0.00

0.0

1.0

—

510.60

—

Other facial nerve disorders

0.91

-0.00

1.1

1.3

609.86

432.88

u/l

—

Use of bromocriptine

0.00

-0.00

0.0

1.3

—

205.93

—

Use of pergolide

0.00

-0.00

0.0

1.6

—

129.00

—

Use of trihexyphenidyl

0.00

-0.00

0.0

1.3

—

277.71

—

Syndactyly, including avohilmo

0.00

-0.00

0.0

1.0

—

333.80

—

Dengue fever [classical dengue], including avohilmo

0.00

-0.00

0.0

1.2

—

364.17

—

Congenital malformations of larynx

0.00

-0.00

0.0

1.0

—

344.92

—

Plasmodium falciparum malaria, including avohilmo

0.00

-0.00

0.0

1.2

—

319.67

—

Other helminthiases, including avohilmo

0.00

-0.00

0.0

1.3

—

252.57

—

Disorders of puberty

0.00

-0.00

0.0

1.3

—

507.86

—

Other congenital malformations of male genital organs, including avohilmo

0.00

-0.00

0.0

1.1

—

581.00

—

Traumatic amputation at neck level

0.00

-0.00

0.0

1.4

—

250.12

—

Other and unspecified syphilis

0.00

-0.00

0.0

1.3

—

266.14

—

Congenital varicose veins

0.00

-0.00

0.0

1.2

—

2143.20

—

Pediculosis and phthiriasis

0.00

-0.00

0.0

1.2

—

228.50

—

Other zoonotic bacterial diseases, not elsewhere classified

0.00

-0.00

0.0

1.0

—

285.52

—

Tetanus, other/unspecified, including avohilmo

0.00

-0.00

0.0

1.2

—

293.20

—

Toxic effect of other noxious substances eaten as food

0.00

-0.00

0.0

1.1

—

233.00

—

Reduction defects of upper limb, including avohilmo

0.00

-0.00

0.0

1.1

—

290.57

—

Other and unspecified syphilis, including avohilmo

0.00

-0.00

0.0

1.3

—

266.14

—

Brain astrocytoma, helper endpoint

0.00

-0.00

0.0

1.3

—

1436.88

—

Acute lymphocytic leukaemia, helper endpoint

0.00

-0.00

0.0

1.1

—

491.14

—

Drug phototoxic response

0.00

-0.00

0.0

1.2

—

300.92

—

Benign neoplasm: Connective and other soft tissue of pelvis

0.00

-0.00

0.0

1.3

—

407.76

—

Intentional self-harm by drowning and submersion

0.00

-0.00

0.0

1.1

—

318.67

—

Congenital edentulism

0.00

-0.00

0.0

1.2

—

310.80

—

Impacted maxillary canine

0.00

-0.00

0.0

1.4

—

312.66

—

Plasmodium falciparum malaria

0.00

-0.00

0.0

1.2

—

319.67

—

Acne conglobata

0.00

-0.00

0.0

1.1

—

1361.96

—

Other and unspecified disorders of sclera

0.00

-0.00

0.0

1.0

—

349.94

—

Other and unspecified disorders of refraction

0.00

-0.00

0.0

1.3

—

301.88

—

Contact with hypodermic needle

0.00

-0.00

0.0

1.3

—

1510.38

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS